{"filter":{"intervention":"fmt"},"n_projects":166,"projects":[{"accession":"PRJEB28097","age_categories":{"adult":1602,"elderly":11},"countries":{},"first_public_year":"2018","gbp_per_sample_median":1.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":1613},"intervention_design":"randomized_controlled_trial","intervention_detail":"11-strain probiotic vs placebo; post-antibiotic probiotic vs autologous FMT","interventions":["antibiotic","fmt","probiotic"],"n_samples":1613,"papers":[{"doi":"10.1186/s40168-021-01015-y","pmcid":"PMC7931531","pmid":"33658077","title":"Accurate and sensitive detection of microbial eukaryotes from whole metagenome shotgun sequencing."},{"doi":"10.1128/mbio.03456-22","pmcid":"PMC9972980","pmid":"36719226","title":"Strains Colonizing Different Intestinal Sites within an Individual Are Derived from a Single Founder Population."},{"doi":"10.1038/s41564-021-00920-0","pmcid":"PMC8318886","pmid":"34226711","title":"Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner."},{"doi":"10.1038/s42003-021-02724-8","pmcid":"PMC8523657","pmid":"34663913","title":"Probiotic consumption influences universal adaptive mutations in indigenous human and mouse gut microbiota."},{"doi":"10.3390/life11111246","pmcid":"PMC8620312","pmid":"34833122","title":"Lacticaseibacillus paracasei: Occurrence in the Human Gut Microbiota and K-Mer-Based Assessment of Intraspecies Diversity."}],"sample_intervention_arms":{"antibiotic":555,"bowel_preparation":20,"fmt":60,"no_intervention":579,"placebo":47,"probiotic":240},"sex":{"female":687,"male":926},"title":"(1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics (2) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB28097","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28097_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB28097.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB28097.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB28097.csv.gz"}},{"accession":"PRJEB72385","age_categories":{"adult":751},"countries":{"CN":751},"first_public_year":"2024","gbp_per_sample_median":10.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":751},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral FMT capsules vs placebo capsules, three visits, in hypertensive patients","interventions":["fmt"],"n_samples":751,"papers":[{"doi":"10.1186/s40168-025-02118-6","pmcid":"PMC12100813","pmid":"40410854","title":"Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal Microbiota Transplantation on Hypertension: an exploratory, multi-center, randomized, blinded, placebo-controlled trial","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB72385","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB72385_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB72385.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB72385.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB72385.csv.gz"}},{"accession":"PRJEB81106","age_categories":{"unknown":450},"countries":{"DE":99,"IL":351},"first_public_year":"2024","gbp_per_sample_median":0.58,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":23,"healthy_control":25,"ulcerative_colitis":146},"intervention_design":"unknown","intervention_detail":"","interventions":[],"n_samples":450,"papers":[{"doi":"10.1016/j.cell.2024.12.016","pmcid":null,"pmid":"39837331","title":"Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease."}],"sample_intervention_arms":{"diet_intervention":91,"fmt":47},"sex":{},"title":"Simultaneous metagenome-informed metaproteomics of the human gut microbiome, host and dietary exposome uncover functional interactomes in health & IBD","trial_population_condition":"ibd_unspecified","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB81106","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB81106_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB81106.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB81106.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB81106.csv.gz"}},{"accession":"PRJNA637785","age_categories":{"adolescent":186,"adult":244},"countries":{"NZ":430},"first_public_year":"2021","gbp_per_sample_median":5.97,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":58,"obesity":372},"intervention_design":"randomized_controlled_trial","intervention_detail":"Multi-donor oral encapsulated FMT from 4 lean donors vs placebo","interventions":["bowel_preparation","fmt"],"n_samples":430,"papers":[{"doi":"10.1186/s40168-021-01060-7","pmcid":"PMC8120839","pmid":"33985595","title":"Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity."},{"doi":"10.1186/s40168-024-01748-6","pmcid":"PMC10860221","pmid":"38347627","title":"Horizontal gene transfer after faecal microbiota transplantation in adolescents with obesity."},{"doi":"10.1186/s40168-024-01833-w","pmcid":"PMC11227244","pmid":"38970126","title":"Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity."},{"doi":"10.1038/s41467-025-62752-4","pmcid":"PMC12394558","pmid":"40877311","title":"Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up."},{"doi":"10.1001/jamanetworkopen.2020.30415","pmcid":"PMC7753902","pmid":"33346848","title":"Effects of Fecal Microbiome Transfer in Adolescents With Obesity"}],"sample_intervention_arms":{"fmt":135,"no_intervention":145,"placebo":150},"sex":{"female":251,"male":179},"title":"Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial)","trial_population_condition":"obesity","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA637785","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA637785_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA637785.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA637785.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA637785.csv.gz"}},{"accession":"PRJEB26472","age_categories":{"adult":426},"countries":{},"first_public_year":"2018","gbp_per_sample_median":0.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":426},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT for active ulcerative colitis (FOCUS study)","interventions":["fmt"],"n_samples":426,"papers":[{"doi":"10.1016/j.chom.2020.03.006","pmcid":"PMC8647676","pmid":"32298656","title":"Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis."}],"sample_intervention_arms":{},"sex":{},"title":"Faecal cDNA Specific bacteria and metabolic pathways are associated with response to faecal microbiota transplantation in ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB26472","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26472_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB26472.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB26472.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26472.csv.gz"}},{"accession":"PRJEB68317","age_categories":{"adult":416},"countries":{"FI":416},"first_public_year":"2024","gbp_per_sample_median":5.18,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":416},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT from two donors vs placebo in Parkinson's disease, 15 placebo and 15+15 FMT","interventions":["fmt"],"n_samples":416,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota transplantation in Parkinson's disease","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB68317","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB68317_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB68317.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB68317.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB68317.csv.gz"}},{"accession":"PRJNA606075","age_categories":{"adult":407},"countries":{},"first_public_year":"2020","gbp_per_sample_median":1.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":407},"intervention_design":"randomized_controlled_trial","intervention_detail":"RBX2660 microbiota suspension vs placebo for recurrent C. difficile","interventions":["fmt"],"n_samples":407,"papers":[{"doi":"10.1186/s40168-020-00907-9","pmcid":"PMC7457799","pmid":"32862830","title":"Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenome sequencing of fecal specimens from the patients before and after the administration of study drugs of RBX2660 and placebo","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA606075","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA606075_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA606075.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA606075.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA606075.csv.gz"}},{"accession":"PRJNA1450848","age_categories":{"unknown":387},"countries":{"CN":387},"first_public_year":"2026","gbp_per_sample_median":9.81,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":56,"ulcerative_colitis":331},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from non-urbanized donors for ulcerative colitis treatment","interventions":["fmt"],"n_samples":387,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Improved Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis with Non-urbanized Donors","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1450848","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1450848_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1450848.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1450848.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1450848.csv.gz"}},{"accession":"PRJNA1056456","age_categories":{"adult":316,"elderly":11},"countries":{"CN":327},"first_public_year":"2024","gbp_per_sample_median":6.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ibs":327},"intervention_design":"non_randomized_controlled","intervention_detail":"Selective microbiota transplantation (SMT) vs fecal microbiota transplantation (FMT)","interventions":["fmt","other_intervention"],"n_samples":327,"papers":[],"sample_intervention_arms":{"fmt":176,"other_intervention":151},"sex":{"female":103,"male":219},"title":"Homo sapiens Metagenome","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1056456","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1056456_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1056456.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1056456.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1056456.csv.gz"}},{"accession":"PRJEB26357","age_categories":{"adult":284},"countries":{},"first_public_year":"2018","gbp_per_sample_median":1.71,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":284},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT (donor faecal microbiota) vs placebo in FOCUS trial for active UC","interventions":["fmt"],"n_samples":284,"papers":[{"doi":"10.1016/j.chom.2020.03.006","pmcid":"PMC8647676","pmid":"32298656","title":"Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis."},{"doi":"10.1038/s41467-024-53454-4","pmcid":"PMC11487140","pmid":"39420033","title":"The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission."},{"doi":"10.1038/s41586-024-08242-x","pmcid":"PMC12547691","pmid":"39604726","title":"Gut microbiota strain richness is species specific and affects engraftment."},{"doi":"10.1080/19490976.2025.2597628","pmcid":"PMC12710892","pmid":"41378445","title":"Cohort-specific determinants of donor strain engraftment following multi-donor faecal microbiota transplantation in two randomised clinical trials."}],"sample_intervention_arms":{},"sex":{},"title":"ShotGun BACTERIAL AND FUNCTIONAL DETERMINANTS OF OUTCOME IN FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE ULCERATIVE COLITIS","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB26357","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26357_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB26357.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB26357.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26357.csv.gz"}},{"accession":"PRJEB61882","age_categories":{"adult":278},"countries":{"GB":278},"first_public_year":"2024","gbp_per_sample_median":13.27,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"liver_disease":278},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT delivered via jejunum vs placebo in advanced cirrhosis patients","interventions":["fmt"],"n_samples":278,"papers":[{"doi":"10.21203/rs.3.rs-3088449/v1","pmcid":null,"pmid":null,"title":"Faecal microbiota transplant restores intestinal barrier function and augments ammonia metabolism in patients with cirrhosis: a randomised single-blind placebo-controlled trial"}],"sample_intervention_arms":{},"sex":{},"title":"PROFIT Trial: FMT in cirrhosis","trial_population_condition":"liver_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB61882","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61882_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB61882.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB61882.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB61882.csv.gz"}},{"accession":"PRJNA871036","age_categories":{"adult":275},"countries":{"HK":275},"first_public_year":"2024","gbp_per_sample_median":8.59,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ibs":275},"intervention_design":"randomized_controlled_trial","intervention_detail":"Twice FMT via OGD, 4-week interval, placebo-controlled, IBS","interventions":["fmt"],"n_samples":275,"papers":[{"doi":"10.1111/apt.17703","pmcid":null,"pmid":"37667968","title":"Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea."}],"sample_intervention_arms":{},"sex":{},"title":"Faecal Microbiota Transplantation in patients with irritable bowel syndrome: a randomized, double-blind, placebo-controlled study","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA871036","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA871036_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA871036.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA871036.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA871036.csv.gz"}},{"accession":"PRJEB94043","age_categories":{"adult":255},"countries":{"IT":255},"first_public_year":"2025","gbp_per_sample_median":11.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":255},"intervention_design":"randomized_controlled_trial","intervention_detail":"Donor FMT vs placebo FMT plus pembrolizumab and axitinib","interventions":["drug_therapy","fmt"],"n_samples":255,"papers":[{"doi":"10.1038/s41591-025-04189-2","pmcid":"PMC13099650","pmid":"41606119","title":"Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial."}],"sample_intervention_arms":{},"sex":{},"title":"Clinical trial (TACITO) for the evaluation of the efficacy of targeted of fecal microbiota transplantation (FMT) in improving response rates to immune checkpoint inhibitors (ICIs) in subjects with treatment-naïve metastatic renal cell carcinoma.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB94043","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB94043_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB94043.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB94043.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB94043.csv.gz"}},{"accession":"PRJNA737472","age_categories":{"adult":224},"countries":{"US":224},"first_public_year":"2022","gbp_per_sample_median":15.09,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":42,"ulcerative_colitis":182},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT with antibiotic pretreatment vs none; capsule vs enema maintenance, 2x2 factorial","interventions":["antibiotic","fmt"],"n_samples":224,"papers":[{"doi":"10.1038/s41598-022-09307-5","pmcid":"PMC8976058","pmid":"35365713","title":"Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis."},{"doi":"10.3389/fbinf.2022.867386","pmcid":"PMC9580935","pmid":"36304283","title":"Scalable Microbial Strain Inference in Metagenomic Data Using StrainFacts."},{"doi":"10.1038/s41598-024-62463-8","pmcid":"PMC11316000","pmid":"39122767","title":"Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients."},{"doi":"10.1101/gr.279543.124","pmcid":"PMC12047655","pmid":"40210439","title":"Accurate estimation of intraspecific microbial gene content variation in metagenomic data with MIDAS v3 and StrainPGC."},{"doi":"10.1016/s0016-5085(20)30716-2","pmcid":null,"pmid":null,"title":"36 ANTIBIOTIC PRETREATMENT PRIOR TO FECAL MICROBIOTA TRANSPLANTATION INCREASES RATES OF REMISSION IN PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: RESULTS FROM A PILOT RANDOMIZED CLINICAL TRIAL"}],"sample_intervention_arms":{"antibiotic":74,"fmt":155,"no_intervention":69},"sex":{"female":69,"male":113},"title":"Microbiome sequencing of ulcerative colitis patients receiving fecal microbiota transplantation","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA737472","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA737472_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA737472.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA737472.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA737472.csv.gz"}},{"accession":"PRJEB58035","age_categories":{"adult":221},"countries":{"AU":221},"first_public_year":"2024","gbp_per_sample_median":11.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ulcerative_colitis":221},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral lyophilized donor FMT vs placebo in ulcerative colitis patients","interventions":["fmt"],"n_samples":221,"papers":[{"doi":"10.1038/s41467-024-53454-4","pmcid":"PMC11487140","pmid":"39420033","title":"The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission."},{"doi":"10.1128/msystems.00991-25","pmcid":"PMC12542657","pmid":"40952001","title":"Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis."}],"sample_intervention_arms":{"fmt":60,"placebo":75},"sex":{},"title":"Patient samples from lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS) study shotgun","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB58035","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58035_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB58035.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB58035.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58035.csv.gz"}},{"accession":"PRJEB22863","age_categories":{"adult":125,"elderly":94},"countries":{"FR":219},"first_public_year":"2017","gbp_per_sample_median":2.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":219},"intervention_design":"observational_with_procedure","intervention_detail":"Anti-PD-1 therapy; FMT and A. muciniphila supplementation in mouse models","interventions":["drug_therapy","fmt","probiotic"],"n_samples":219,"papers":[{"doi":"10.1126/science.aan3706","pmcid":null,"pmid":"29097494","title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors."},{"doi":"10.3389/fonc.2022.837525","pmcid":"PMC9069064","pmid":"35530307","title":"Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients."},{"doi":"10.1186/s12967-025-06370-0","pmcid":"PMC11916936","pmid":"40098172","title":"Prioritizing gut microbial SNPs linked to immunotherapy outcomes in NSCLC patients by integrative bioinformatics analysis."},{"doi":"10.1126/sciadv.aaz2299","pmcid":"PMC7176420","pmid":"32494636","title":"Metagenomic growth rate inferences of strains in situ."},{"doi":"10.1084/jem.20200606","pmcid":"PMC7664509","pmid":"33175106","title":"Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers."}],"sample_intervention_arms":{"drug_therapy":92,"no_intervention":127},"sex":{"female":47,"male":127},"title":"Gut mictobiota composition correlation with the clinical outcome of NSCLC and RCC patients treated with anti-PD-1 mAB","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB22863","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22863_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB22863.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB22863.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB22863.csv.gz"}},{"accession":"PRJNA1289847","age_categories":{"adult":216},"countries":{"CA":216},"first_public_year":"2025","gbp_per_sample_median":8.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":89},"intervention_design":"single_arm_before_after","intervention_detail":"Healthy donor FMT (oral capsules) plus anti-PD-1 ± anti-CTLA-4","interventions":["drug_therapy","fmt"],"n_samples":216,"papers":[{"doi":"10.1038/s41591-025-04186-5","pmcid":"PMC13099432","pmid":"41606121","title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial."}],"sample_intervention_arms":{"fmt":214},"sex":{"female":5,"male":28},"title":"Gut microbiota composition of patients in FMT-LUMINate clinical trial","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1289847","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1289847_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1289847.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1289847.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1289847.csv.gz"}},{"accession":"PRJNA672867","age_categories":{"adult":134,"elderly":82},"countries":{"US":216},"first_public_year":"2020","gbp_per_sample_median":2.19,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_cancer":216},"intervention_design":"single_arm_before_after","intervention_detail":"Responder-derived FMT combined with anti-PD-1 therapy in refractory melanoma","interventions":["drug_therapy","fmt"],"n_samples":216,"papers":[{"doi":"10.1126/science.abf3363","pmcid":"PMC8097968","pmid":"33542131","title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients."},{"doi":"10.1371/journal.pone.0274633","pmcid":"PMC9477264","pmid":"36107983","title":"Time series strain tracking analysis post fecal transplantation identifies individual specific patterns of fecal dominant donor, recipient, and unrelated microbial strains."},{"doi":"10.1186/s12866-021-02312-0","pmcid":"PMC8454007","pmid":"34544375","title":"Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy."},{"doi":"10.1126/science.aaz7015","pmcid":"PMC8970537","pmid":"34941392","title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response."},{"doi":"10.1126/sciimmunol.abn0704","pmcid":"PMC9925043","pmid":"36083892","title":"The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer."}],"sample_intervention_arms":{"fmt":167,"no_intervention":49},"sex":{"female":65,"male":151},"title":"Effectiveness of Fecal Microbiota Transplant together with PD-1 blockade in overcoming resistance to anti-PD-1 therapy in advanced melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA672867","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA672867_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA672867.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA672867.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA672867.csv.gz"}},{"accession":"PRJNA475599","age_categories":{"adult":215},"countries":{"US":215},"first_public_year":"2019","gbp_per_sample_median":0.8,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":13,"ulcerative_colitis":202},"intervention_design":"randomized_controlled_trial","intervention_detail":"Colonoscopy FMT induction + 12wk daily encapsulated oral FMT vs sham","interventions":["fmt"],"n_samples":215,"papers":[{"doi":"10.1186/s12876-021-01856-9","pmcid":"PMC8268596","pmid":"34238227","title":"Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study."},{"doi":"10.1128/mbio.00975-21","pmcid":"PMC8406238","pmid":"34281401","title":"Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease."}],"sample_intervention_arms":{"fmt":84,"no_intervention":41,"placebo":74},"sex":{},"title":"Fecal transplant for ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA475599","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA475599_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA475599.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA475599.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA475599.csv.gz"}},{"accession":"PRJEB53551","age_categories":{"adult":212},"countries":{},"first_public_year":"2024","gbp_per_sample_median":7.37,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":27,"type2_diabetes":185},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in diabetic peripheral neuropathy patients","interventions":["fmt"],"n_samples":212,"papers":[],"sample_intervention_arms":{"fmt":105,"placebo":45},"sex":{},"title":"FMT alleviates peripheral neuropathy in patients with diabetes mellitus","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB53551","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53551_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB53551.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB53551.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53551.csv.gz"}},{"accession":"PRJNA1071720","age_categories":{"unknown":209},"countries":{"NL":209},"first_public_year":"2024","gbp_per_sample_median":0.29,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":27,"ulcerative_colitis":182},"intervention_design":"randomized_controlled_trial","intervention_detail":"Budesonide or placebo pretreatment then 4 FMT infusions from selected donors","interventions":["drug_therapy","fmt"],"n_samples":209,"papers":[{"doi":"10.1093/ecco-jcc/jjae043","pmcid":"PMC11369067","pmid":"38572716","title":"Fecal Microbiota Transplantation engraftment after budesonide or placebo in patients with active ulcerative colitis using pre-selected donors: a randomized pilot study."},{"doi":"10.1093/ecco-jcc/jjae137","pmcid":"PMC11836888","pmid":"39225490","title":"Dynamics of Gut Microbiota After Fecal Microbiota Transplantation in Ulcerative Colitis: Success Linked to Control of Prevotellaceae."},{"doi":"10.1093/ismeco/ycaf119","pmcid":"PMC12378841","pmid":"40873786","title":"Ecological resilience in ulcerative colitis: microbial dynamics of donor and resident species in a longitudinal fecal microbiota transplantation study."},{"doi":"10.1038/s41467-026-73290-y","pmcid":"PMC13376552","pmid":"42151161","title":"Inorganic nitrogen metabolic reprogramming of the gut microbiome drives fecal microbiota transplantation in ulcerative colitis."}],"sample_intervention_arms":{},"sex":{},"title":"FECBUD Study Fecal Metagenomes","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1071720","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1071720_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1071720.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1071720.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1071720.csv.gz"}},{"accession":"PRJEB13870","age_categories":{"adult":196},"countries":{"CN":196},"first_public_year":"2016","gbp_per_sample_median":5.34,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":155,"healthy_control":40},"intervention_design":"observational_with_procedure","intervention_detail":"FMT from hypertensive/pre-hypertensive patients to germ-free mice","interventions":["fmt"],"n_samples":196,"papers":[{"doi":"10.1073/pnas.2023202118","pmcid":"PMC8201803","pmid":"34083435","title":"A catalog of tens of thousands of viruses from human metagenomes reveals hidden associations with chronic diseases."},{"doi":"10.1186/s40168-016-0222-x","pmcid":"PMC5286796","pmid":"28143587","title":"Gut microbiota dysbiosis contributes to the development of hypertension."},{"doi":"10.3389/fmicb.2018.03150","pmcid":"PMC6305721","pmid":"30619215","title":"The Human Gut Virome in Hypertension."},{"doi":"10.1038/s41467-020-15222-y","pmcid":"PMC7080799","pmid":"32188862","title":"Environmental remodeling of human gut microbiota and antibiotic resistome in livestock farms."},{"doi":"10.1038/s41467-020-16990-3","pmcid":"PMC7316982","pmid":"32587239","title":"Alterations of gut microbiota contribute to the progression of unruptured intracranial aneurysms."}],"sample_intervention_arms":{},"sex":{"female":19,"male":173},"title":"Hypertension is one of the most prevalent cardiovascular diseases worldwide. Recent findings have identified a link between gut microbiota and blood pressure, yet the contributions of gut microbes and bacterial metabolites towards hypertension remain largely uncharacterized. We carried out metagenomic and metabonomics analyses, in combination with faecal microbiota transplantation, and elucidate that dysbiosis of gut microbiome triggers the pathogenesis of hypertension through altering the metabolic effects.","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB13870","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB13870_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB13870.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB13870.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB13870.csv.gz"}},{"accession":"PRJNA1314234","age_categories":{"unknown":194},"countries":{"CA":194},"first_public_year":"2025","gbp_per_sample_median":3.05,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from ir-colitis patient into antibiotic-pretreated tumor-bearing mice","interventions":["antibiotic","fmt"],"n_samples":194,"papers":[{"doi":"10.1186/s40168-026-02419-4","pmcid":"PMC13288583","pmid":"42083059","title":"Metagenomics and culturomics reveal the dual role of the gut microbiome in the development of immune-related toxicities and the efficacy of immune checkpoint inhibitors in cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Human and mouse gut microbiome sequencing datasets related to immune checkpoint inhibitor therapy and immune-related adverse events.","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1314234","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1314234_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1314234.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1314234.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1314234.csv.gz"}},{"accession":"PRJNA674880","age_categories":{"adult":193},"countries":{"US":193},"first_public_year":"2020","gbp_per_sample_median":0.59,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":149,"healthy_control":44},"intervention_design":"single_arm_before_after","intervention_detail":"RBX2660 microbiota-based FMT, 1 or 2 doses, recurrent CDI","interventions":["fmt"],"n_samples":193,"papers":[{"doi":"10.1186/s13073-021-00843-9","pmcid":"PMC7888090","pmid":"33593430","title":"Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota Restoration Reduces Antibiotic Resistant Bacteria Gut Colonization in Patients with Recurrent Clostridioides difficile Infection from the Open-Label PUNCH CD Study","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA674880","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA674880_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA674880.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA674880.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA674880.csv.gz"}},{"accession":"PRJNA844888","age_categories":{"unknown":188},"countries":{"US":188},"first_public_year":"2025","gbp_per_sample_median":7.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":188},"intervention_design":"randomized_controlled_trial","intervention_detail":"Encapsulated microbiota transplant therapy (MTP-101C) vs placebo capsules, 8 weeks, UC","interventions":["fmt"],"n_samples":188,"papers":[{"doi":"10.1093/ecco-jcc/jjae142","pmcid":"PMC12476944","pmid":"39240145","title":"Novel Microbial Engraftment Trajectories Following Microbiota Transplant Therapy in Ulcerative Colitis."}],"sample_intervention_arms":{"fmt":103},"sex":{},"title":"Vaughn UC IMT Study","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA844888","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA844888_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA844888.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA844888.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA844888.csv.gz"}},{"accession":"PRJEB66493","age_categories":{"adult":177},"countries":{"DK":177},"first_public_year":"2024","gbp_per_sample_median":2.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":63},"intervention_design":"randomized_controlled_trial","intervention_detail":"Non-pooled multi-donor FMT by enema for 4 weeks","interventions":["fmt"],"n_samples":177,"papers":[{"doi":"10.1080/19490976.2025.2510464","pmcid":"PMC12118383","pmid":"40413728","title":"Fecal microbiota transplantation from a healthy pouch donor for chronic pouchitis: a proof-of-concept study."}],"sample_intervention_arms":{},"sex":{},"title":"A Randomised Placebo-Controlled Trial of Faecal Microbiota Transplantation in Patients with Chronic Pouchitis – MicroPouch study","trial_population_condition":"ibd_or_gi_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB66493","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB66493_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB66493.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB66493.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB66493.csv.gz"}},{"accession":"PRJEB53547","age_categories":{"adult":176},"countries":{"DE":176},"first_public_year":"2023","gbp_per_sample_median":1.82,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":176},"intervention_design":"observational_with_procedure","intervention_detail":"FMT in allo-SCT patients as proof-of-concept microbiome modulation","interventions":["fmt"],"n_samples":176,"papers":[{"doi":"10.1038/s43018-023-00669-x","pmcid":"PMC12063274","pmid":"38172339","title":"Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"MultiOmics_aSCT","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB53547","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53547_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB53547.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB53547.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB53547.csv.gz"}},{"accession":"PRJEB49147","age_categories":{"adult":173},"countries":{"IL":173},"first_public_year":"2022","gbp_per_sample_median":4.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"obesity":173},"intervention_design":"randomized_controlled_trial","intervention_detail":"MED/Green-MED diet, walnuts, Mankai/green tea; later autologous FMT capsules","interventions":["diet_intervention","dietary_supplement","fmt"],"n_samples":173,"papers":[{"doi":"10.1186/s13073-022-01015-z","pmcid":"PMC8908597","pmid":"35264213","title":"The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial."},{"doi":"10.1080/19490976.2023.2264457","pmcid":"PMC10557561","pmid":"37796016","title":"Successful weight regain attenuation by autologous fecal microbiota transplantation is associated with non-core gut microbiota changes during weight loss; randomized controlled trial."}],"sample_intervention_arms":{},"sex":{},"title":"DIRECT PLUS 6-month Shotgun Metagenomics data","trial_population_condition":"obesity","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB49147","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB49147_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB49147.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB49147.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB49147.csv.gz"}},{"accession":"PRJEB29127","age_categories":{"adolescent":17,"adult":154},"countries":{"CN":171},"first_public_year":"2020","gbp_per_sample_median":11.32,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":90},"intervention_design":"observational_with_procedure","intervention_detail":"FMT of human faeces from SCZ patients/controls into mice","interventions":["fmt"],"n_samples":171,"papers":[{"doi":"10.1038/s41467-020-15457-9","pmcid":"PMC7109134","pmid":"32235826","title":"Metagenome-wide association of gut microbiome features for schizophrenia."},{"doi":"10.1186/s12967-025-06923-3","pmcid":"PMC12341127","pmid":"40790223","title":"Metagenome-based characterization of the gut virome in patients with schizophrenia."},{"doi":"10.1016/j.xgen.2022.100219","pmcid":"PMC9903723","pmid":"36778050","title":"Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases."},{"doi":"10.1038/s43587-022-00306-9","pmcid":"PMC10154212","pmid":"37118093","title":"Toward an improved definition of a healthy microbiome for healthy aging."},{"doi":"10.1038/s41564-023-01381-3","pmcid":"PMC10234815","pmid":"37188815","title":"Reconstruction of the personal information from human genome reads in gut metagenome sequencing data."}],"sample_intervention_arms":{},"sex":{"female":84,"male":87},"title":"A causal role of the gut microbiome in schizophrenia","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB29127","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB29127_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB29127.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB29127.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB29127.csv.gz"}},{"accession":"PRJNA1283919","age_categories":{"adult":166},"countries":{"GB":166},"first_public_year":"2025","gbp_per_sample_median":6.46,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":34,"ulcerative_colitis":132},"intervention_design":"randomized_controlled_trial","intervention_detail":"Multidose FMT via nasogastric tube vs colonoscopy/enema in ulcerative colitis","interventions":["fmt"],"n_samples":166,"papers":[{"doi":"10.1093/ecco-jcc/jjag006","pmcid":"PMC13012878","pmid":"41587946","title":"Mechanistic insights into fecal microbiota transplantation for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial."}],"sample_intervention_arms":{},"sex":{},"title":"STOP-COLITIS Metagenomic Sequencing Data","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1283919","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1283919_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1283919.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1283919.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1283919.csv.gz"}},{"accession":"PRJEB26473","age_categories":{"adult":160},"countries":{},"first_public_year":"2018","gbp_per_sample_median":0.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":160},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in active ulcerative colitis (FOCUS trial)","interventions":["fmt"],"n_samples":160,"papers":[{"doi":"10.1038/s41467-024-46983-5","pmcid":"PMC10965925","pmid":"38531874","title":"Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice."},{"doi":"10.1016/j.chom.2020.03.006","pmcid":"PMC8647676","pmid":"32298656","title":"Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis."}],"sample_intervention_arms":{},"sex":{},"title":"biopsy cDNA Specific bacteria and metabolic pathways are associated with response to faecal microbiota transplantation in ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB26473","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26473_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB26473.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB26473.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26473.csv.gz"}},{"accession":"PRJEB26474","age_categories":{"adult":160},"countries":{},"first_public_year":"2018","gbp_per_sample_median":0.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":160},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in active ulcerative colitis (FOCUS trial)","interventions":["fmt"],"n_samples":160,"papers":[{"doi":"10.1016/j.chom.2020.03.006","pmcid":"PMC8647676","pmid":"32298656","title":"Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis."}],"sample_intervention_arms":{},"sex":{},"title":"biopsy DNA Specific bacteria and metabolic pathways are associated with response to faecal microbiota transplantation in ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB26474","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26474_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB26474.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB26474.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB26474.csv.gz"}},{"accession":"PRJEB47061","age_categories":{"unknown":160},"countries":{"AT":160},"first_public_year":"2021","gbp_per_sample_median":6.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ulcerative_colitis":122},"intervention_design":"unknown","intervention_detail":"FMT for ulcerative colitis; donor stool transplant","interventions":["antibiotic","bowel_preparation","fmt"],"n_samples":160,"papers":[{"doi":"10.1016/j.xcrm.2022.100711","pmcid":"PMC9418803","pmid":"35931074","title":"Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics."}],"sample_intervention_arms":{"fmt":122,"no_intervention":38},"sex":{},"title":"Fecal microbiota transplantation for treatment of ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB47061","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB47061_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB47061.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB47061.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB47061.csv.gz"}},{"accession":"PRJEB44737","age_categories":{"unknown":156},"countries":{"NL":156},"first_public_year":"2022","gbp_per_sample_median":5.5,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":100,"healthy_control":56},"intervention_design":"observational_with_procedure","intervention_detail":"FMT for recurrent C. difficile infection, donor vs recipient samples","interventions":["fmt"],"n_samples":156,"papers":[{"doi":"10.1053/j.gastro.2021.06.009","pmcid":null,"pmid":"34126062","title":"Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients."},{"doi":"10.1038/s41467-025-56449-x","pmcid":"PMC11782615","pmid":"39885121","title":"Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status."},{"doi":"10.1186/s13073-024-01306-7","pmcid":"PMC10902993","pmid":"38419010","title":"Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection."},{"doi":"10.1038/s41586-024-08242-x","pmcid":"PMC12547691","pmid":"39604726","title":"Gut microbiota strain richness is species specific and affects engraftment."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic shotgun sequencing of healthy stool bank donors and multiple recurrent Clostridioides infected recipients from the Netherlands Donor Feces Bank","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB44737","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44737_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB44737.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB44737.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44737.csv.gz"}},{"accession":"PRJEB35816","age_categories":{"adult":152},"countries":{"CH":152},"first_public_year":"2020","gbp_per_sample_median":1.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Oral colistin/neomycin then FMT vs treatment-naive controls","interventions":["antibiotic","fmt"],"n_samples":152,"papers":[{"doi":"10.3390/microorganisms8060941","pmcid":"PMC7357103","pmid":"32585945","title":"Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbi"}],"sample_intervention_arms":{},"sex":{},"title":"Gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB35816","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35816_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB35816.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB35816.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35816.csv.gz"}},{"accession":"PRJEB51776","age_categories":{"adolescent":20,"adult":127},"countries":{"DK":147},"first_public_year":"2023","gbp_per_sample_median":2.98,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":70,"other_disease":77},"intervention_design":"observational_with_procedure","intervention_detail":"FMT from AN patients to germ-free mice (animal experiment)","interventions":["fmt"],"n_samples":147,"papers":[{"doi":"10.1038/s41564-023-01355-5","pmcid":"PMC10159860","pmid":"37069399","title":"The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice."}],"sample_intervention_arms":{},"sex":{"female":147},"title":"Disrupted intestinal microbiota contributes to the pathogenesis of anorexia nervosa","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB51776","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB51776_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB51776.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB51776.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB51776.csv.gz"}},{"accession":"PRJNA491657","age_categories":{"adult":140},"countries":{"US":140},"first_public_year":"2020","gbp_per_sample_median":3.4,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Autologous fecal microbiota transplant in allo-HSCT patients","interventions":["fmt"],"n_samples":140,"papers":[{"doi":"10.1038/s41596-022-00738-y","pmcid":"PMC9725748","pmid":"36171387","title":"Metagenome analysis using the Kraken software suite."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota of allo-HSCT patients and in the setting of Autologous Fecal Microbiota Transplant (auto-FMT) at MSKCC Raw sequence reads","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA491657","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA491657_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA491657.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA491657.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA491657.csv.gz"}},{"accession":"PRJNA446038","age_categories":{"unknown":134},"countries":{"FI":134},"first_public_year":"2019","gbp_per_sample_median":0.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from 3 donors to 14 recipients (recurrent C. difficile infection), viral tracking","interventions":["fmt"],"n_samples":134,"papers":[{"doi":"10.1186/s40168-018-0598-x","pmcid":"PMC6288847","pmid":"30526683","title":"Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation."}],"sample_intervention_arms":{"fmt":97,"no_intervention":33},"sex":{},"title":"viral metagenome Raw sequence reads","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA446038","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA446038_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA446038.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA446038.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA446038.csv.gz"}},{"accession":"PRJEB65418","age_categories":{"unknown":133},"countries":{"FI":133},"first_public_year":"2024","gbp_per_sample_median":1.01,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":4,"ibs":129},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in IBS patients from healthy donor","interventions":["fmt"],"n_samples":133,"papers":[{"doi":"10.1038/s41522-024-00549-x","pmcid":"PMC11349920","pmid":"39191760","title":"Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients."}],"sample_intervention_arms":{"fmt":79,"no_intervention":4,"placebo":50},"sex":{},"title":"Fecal microbiota transplantation in irritable bowel syndrome patients","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB65418","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB65418_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB65418.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB65418.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB65418.csv.gz"}},{"accession":"PRJEB102130","age_categories":{"adult":132},"countries":{"KR":132},"first_public_year":"2026","gbp_per_sample_median":5.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":132},"intervention_design":"single_arm_before_after","intervention_detail":"FMT for CPE decolonization, baseline through week 5","interventions":["fmt"],"n_samples":132,"papers":[{"doi":"10.1093/infdis/jiag414","pmcid":null,"pmid":"42583799","title":"Fecal microbiota transplantation accelerates clearance of carbapenemase-producing Enterobacterales intestinal carriage: influence of recipient gut microbiome ecology."}],"sample_intervention_arms":{"fmt":132},"sex":{},"title":"Shotgun metagenomics of FMT for CPE decolonization","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB102130","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB102130_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB102130.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB102130.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB102130.csv.gz"}},{"accession":"PRJEB46778","age_categories":{"adult":126,"elderly":4},"countries":{"NL":130},"first_public_year":"2022","gbp_per_sample_median":6.47,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"cardiometabolic_other":130},"intervention_design":"randomized_controlled_trial","intervention_detail":"Lean donor (allogenic) vs autologous FMT in metabolic syndrome patients","interventions":["fmt"],"n_samples":130,"papers":[{"doi":"10.1126/science.aad8852","pmcid":null,"pmid":"27126044","title":"Durable coexistence of donor and recipient strains after fecal microbiota transplantation."},{"doi":"10.1016/j.cmet.2017.09.008","pmcid":null,"pmid":"28978426","title":"Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition."},{"doi":"10.1038/s41591-022-01913-0","pmcid":"PMC9499871","pmid":"36109636","title":"Drivers and determinants of strain dynamics following fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":88,"no_intervention":26},"sex":{"male":121},"title":"Fecal Microbiota Transplantation for Metabolic Syndrome","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB46778","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46778_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB46778.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB46778.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46778.csv.gz"}},{"accession":"PRJEB91891","age_categories":{"adult":127},"countries":{"AT":104,"DE":23},"first_public_year":"2025","gbp_per_sample_median":4.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":127},"intervention_design":"single_arm_before_after","intervention_detail":"FMT in aGvHD patients, samples before and after","interventions":["fmt"],"n_samples":127,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Metagenome in allo-SCT -/+ FMT","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB91891","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91891_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB91891.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB91891.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB91891.csv.gz"}},{"accession":"PRJNA1169096","age_categories":{"adult":118,"elderly":9},"countries":{"US":127},"first_public_year":"2025","gbp_per_sample_median":6.11,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ulcerative_colitis":127},"intervention_design":"randomized_controlled_trial","intervention_detail":"Single-dose FMT vs placebo, with/without psyllium fiber, 8 weeks","interventions":["fmt","prebiotic_or_fibre"],"n_samples":127,"papers":[{"doi":"10.1016/j.medj.2025.100707","pmcid":"PMC12353604","pmid":"40460824","title":"Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis."}],"sample_intervention_arms":{"fmt":67,"placebo":35},"sex":{"female":40,"male":86},"title":"Donor Composition and Fiber Promote Strain Engraftment in a Randomized Controlled Trial of Fecal Transplant with Dietary Fiber for Ulcerative Colitis (MINDFUL)","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1169096","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1169096_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1169096.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1169096.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1169096.csv.gz"}},{"accession":"PRJNA240307","age_categories":{"unknown":127},"countries":{"US":127},"first_public_year":"2014","gbp_per_sample_median":9.01,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"unknown","intervention_detail":"FMT for C. difficile infection","interventions":["fmt"],"n_samples":127,"papers":[{"doi":"10.1128/msystems.00019-22","pmcid":"PMC9426582","pmid":"35762793","title":"Phage Cocktails Constrain the Growth of Enterococcus."}],"sample_intervention_arms":{},"sex":{},"title":"C.diff FMT","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA240307","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA240307_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA240307.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA240307.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA240307.csv.gz"}},{"accession":"PRJEB44237","age_categories":{"adult":124},"countries":{"NL":124},"first_public_year":"2021","gbp_per_sample_median":5.3,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"obesity":124},"intervention_design":"randomized_controlled_trial","intervention_detail":"Mediterranean diet + lean donor vs autologous FMT, 6 weeks","interventions":["diet_intervention","fmt"],"n_samples":124,"papers":[{"doi":"10.3389/fmicb.2021.662159","pmcid":"PMC8222733","pmid":"34177842","title":"Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome."}],"sample_intervention_arms":{},"sex":{"male":124},"title":"Effect of fecal microbiota transplantation combined with Mediterranean diet on insulin sensitivity in subjects with metabolic syndrome","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB44237","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44237_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB44237.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB44237.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB44237.csv.gz"}},{"accession":"PRJNA739170","age_categories":{"adult":118},"countries":{},"first_public_year":"2022","gbp_per_sample_median":6.53,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Single colonoscopic FMT, pre/1wk/3mo post, rCDI and/or IBD","interventions":["fmt"],"n_samples":118,"papers":[{"doi":"10.18103/mra.v10i10.3318","pmcid":"PMC9817289","pmid":"36618438","title":"Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases."}],"sample_intervention_arms":{},"sex":{},"title":"FMT in recurrent C. Difficile and or IBD (inflammatory bowel diseases)","trial_population_condition":"ibd_or_gi_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA739170","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA739170_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA739170.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA739170.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA739170.csv.gz"}},{"accession":"PRJNA1056888","age_categories":{"adult":116},"countries":{"HK":116},"first_public_year":"2024","gbp_per_sample_median":7.51,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"Faecal microbiota transplantation for sleep disturbance in post-COVID-19","interventions":["fmt"],"n_samples":116,"papers":[{"doi":"10.1016/j.cgh.2024.06.004","pmcid":null,"pmid":"38908733","title":"Fecal Microbiota Transplantation for Sleep Disturbance in Post-acute COVID-19 Syndrome."}],"sample_intervention_arms":{},"sex":{},"title":"Faecal microbiota transplantation for sleep disturbance in post-acute COVID-19 syndrome","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1056888","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1056888_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1056888.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1056888.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1056888.csv.gz"}},{"accession":"PRJNA701480","age_categories":{"adult":25,"infant":77,"neonate":14},"countries":{"NZ":116},"first_public_year":"2021","gbp_per_sample_median":5.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":91},"intervention_design":"randomized_controlled_trial","intervention_detail":"Vaginal seeding: maternal vaginal microbes vs sterile water placebo at birth","interventions":["fmt"],"n_samples":116,"papers":[{"doi":"10.1016/j.ebiom.2021.103443","pmcid":"PMC8254083","pmid":"34186487","title":"Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial."},{"doi":"10.1080/19490976.2022.2118811","pmcid":"PMC9467569","pmid":"36093611","title":"Infant gut microbiota restoration: state of the art."}],"sample_intervention_arms":{"other_intervention":24,"placebo":26},"sex":{"female":70,"male":46},"title":"Vaginal seeding in babies born by caesarean section (ECOBABe trial) - shotgun metagenomics data","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA701480","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA701480_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA701480.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA701480.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA701480.csv.gz"}},{"accession":"PRJEB47909","age_categories":{"adult":115},"countries":{"IT":115},"first_public_year":"2022","gbp_per_sample_median":6.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":1,"ibd_unspecified":6,"other_infection":95},"intervention_design":"observational_with_procedure","intervention_detail":"Fecal microbiota transplantation in rCDI, IBD, MDRB colonization patients","interventions":["fmt"],"n_samples":115,"papers":[{"doi":"10.1038/s41591-022-01964-3","pmcid":"PMC9499858","pmid":"36109637","title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases."},{"doi":"10.1186/s40168-025-02051-8","pmcid":"PMC11869744","pmid":"40022204","title":"Shared environments complicate the use of strain-resolved metagenomics to infer microbiome transmission."},{"doi":"10.1038/s41564-026-02339-x","pmcid":"PMC13236588","pmid":"42032281","title":"Strain-level transmission inference across multi-kingdom metagenomic data using TRACS."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"FMT datasets of patients with recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and colonization from multi-drug resistant bacteria (MDRB)","trial_population_condition":"ibd_or_gi_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB47909","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB47909_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB47909.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB47909.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB47909.csv.gz"}},{"accession":"PRJNA625520","age_categories":{"adult":115},"countries":{"FR":115},"first_public_year":"2020","gbp_per_sample_median":6.42,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":115},"intervention_design":"single_arm_before_after","intervention_detail":"FMT in CD patients in remission, pre/post sampling","interventions":["fmt"],"n_samples":115,"papers":[{"doi":"10.1053/j.gastro.2020.08.045","pmcid":"PMC7725862","pmid":"32860788","title":"Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease."},{"doi":"10.3390/microorganisms10101910","pmcid":"PMC9610947","pmid":"36296186","title":"Individuals with Inflammatory Bowel Disease Have an Altered Gut Microbiome Composition of Fungi and Protozoa."},{"doi":"10.1002/imt2.41","pmcid":"PMC10989911","pmid":"38868710","title":"StrainPanDA: Linked reconstruction of strain composition and gene content profiles via pangenome-based decomposition of metagenomic data."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."},{"doi":"10.1016/j.isci.2026.116025","pmcid":"PMC13213781","pmid":"42211136","title":"Cohesive modules of engraftment in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":115},"sex":{"male":115},"title":"Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA625520","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA625520_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA625520.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA625520.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA625520.csv.gz"}},{"accession":"PRJNA1290813","age_categories":{"adult":113},"countries":{"CA":113},"first_public_year":"2025","gbp_per_sample_median":15.12,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":113},"intervention_design":"single_arm_before_after","intervention_detail":"Encapsulated donor FMT plus ICI therapy (ipilimumab/nivolumab or pembrolizumab combos)","interventions":["drug_therapy","fmt"],"n_samples":113,"papers":[{"doi":"10.1038/s41591-025-04183-8","pmcid":"PMC13099417","pmid":"41606120","title":"Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial."}],"sample_intervention_arms":{},"sex":{},"title":"FMT plus systemic therapy in renal cell cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1290813","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1290813_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1290813.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1290813.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1290813.csv.gz"}},{"accession":"PRJEB23524","age_categories":{"adult":110},"countries":{"US":110},"first_public_year":"2017","gbp_per_sample_median":8.49,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":110},"intervention_design":"observational_with_procedure","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile infection","interventions":["fmt"],"n_samples":110,"papers":[{"doi":"10.1016/j.chom.2018.01.003","pmcid":"PMC8318347","pmid":"29447696","title":"Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation."},{"doi":"10.1089/crispr.2018.0046","pmcid":"PMC6390457","pmid":"30820491","title":"CRISPRs for Strain Tracking and Their Application to Microbiota Transplantation Data Analysis."},{"doi":"10.1038/s41467-020-19940-1","pmcid":"PMC7719190","pmid":"33277504","title":"Deciphering functional redundancy in the human microbiome."},{"doi":"10.1080/19490976.2022.2135963","pmcid":"PMC9621045","pmid":"36289064","title":"Functional profile of host microbiome indicates Clostridioides difficile infection."},{"doi":"10.1038/s41522-023-00421-4","pmcid":"PMC10400536","pmid":"37537181","title":"Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms."}],"sample_intervention_arms":{},"sex":{},"title":"WGS data from FMT trial for the treatment of recurrent Clostridium difficile infection","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB23524","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB23524_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB23524.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB23524.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB23524.csv.gz"}},{"accession":"PRJNA701961","age_categories":{"unknown":109},"countries":{"CA":109},"first_public_year":"2021","gbp_per_sample_median":9.51,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":51,"healthy_control":29,"ulcerative_colitis":19},"intervention_design":"observational_with_procedure","intervention_detail":"FMT for recurrent C. difficile infection from healthy donors","interventions":["fmt"],"n_samples":109,"papers":[{"doi":"10.1186/s13059-023-02924-x","pmcid":"PMC10108530","pmid":"37069665","title":"Metabolic independence drives gut microbial colonization and resilience in health and disease."},{"doi":"10.1101/2021.03.02.433653","pmcid":null,"pmid":null,"title":"Adaptive ecological processes and metabolic independence drive microbial colonization and resilience in the human gut"},{"doi":"10.1080/19490976.2022.2135963","pmcid":"PMC9621045","pmid":"36289064","title":"Functional profile of host microbiome indicates Clostridioides difficile infection."},{"doi":"10.1016/j.chom.2024.03.005","pmcid":"PMC11081829","pmid":"38565143","title":"A metagenomics pipeline reveals insertion sequence-driven evolution of the microbiota."},{"doi":"10.1093/bioinformatics/btae252","pmcid":"PMC11211831","pmid":"38940183","title":"Floria: fast and accurate strain haplotyping in metagenomes."}],"sample_intervention_arms":{"fmt":70,"no_intervention":39},"sex":{},"title":"Donor and recipient stool metagenomes from a fecal microbiota transplantation study","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA701961","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA701961_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA701961.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA701961.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA701961.csv.gz"}},{"accession":"PRJNA786259","age_categories":{"unknown":104},"countries":{"CN":104},"first_public_year":"2025","gbp_per_sample_median":13.03,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"neurological_psychiatric":104},"intervention_design":"single_arm_before_after","intervention_detail":"FMT effect on gut microbiota in autism patients","interventions":["fmt"],"n_samples":104,"papers":[],"sample_intervention_arms":{"fmt":40,"no_intervention":45},"sex":{},"title":"Homo sapiens Raw sequence reads","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA786259","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA786259_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA786259.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA786259.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA786259.csv.gz"}},{"accession":"PRJNA1214038","age_categories":{"unknown":102},"countries":{"CZ":102},"first_public_year":"2025","gbp_per_sample_median":2.17,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ibs":102},"intervention_design":"unknown","intervention_detail":"Double-blind, randomised, cross-over FMT vs autoclaved placebo in IBS","interventions":["fmt"],"n_samples":102,"papers":[],"sample_intervention_arms":{"fmt":50,"placebo":50},"sex":{},"title":"The faecal bacteriome in patients with irritable bowel syndrome","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1214038","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1214038_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1214038.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1214038.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1214038.csv.gz"}},{"accession":"PRJEB115184","age_categories":{"adult":99},"countries":{"IN":99},"first_public_year":"2026","gbp_per_sample_median":7.4,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"crohns_disease":99},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT plus CDED vs sham FMT plus CDED, 52-week trial in Crohn's disease","interventions":["diet_intervention","fmt"],"n_samples":99,"papers":[],"sample_intervention_arms":{"fmt":53,"placebo":22},"sex":{},"title":"Clinical outcomes and microbiome restructuring following fecal microbiota transplantation plus exclusion diet in Crohn’s disease: A 52-week randomized sham-controlled trial","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB115184","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB115184_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB115184.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB115184.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB115184.csv.gz"}},{"accession":"PRJNA1268178","age_categories":{"adult":98},"countries":{"NZ":98},"first_public_year":"2025","gbp_per_sample_median":5.97,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_disease":98},"intervention_design":"single_arm_before_after","intervention_detail":"Encapsulated multi-donor faecal microbiota transfer, 20 capsules/4 donors","interventions":["fmt"],"n_samples":98,"papers":[{"doi":"10.1038/s41467-025-67267-6","pmcid":"PMC12808231","pmid":"41392089","title":"Encapsulated faecal microbiota transfer in young women with anorexia nervosa: an open-label feasibility pilot trial."}],"sample_intervention_arms":{"fmt":63,"no_intervention":29},"sex":{"female":98},"title":"Gut Bugs in Anorexia Nervosa Trial","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1268178","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1268178_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1268178.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1268178.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1268178.csv.gz"}},{"accession":"PRJNA728680","age_categories":{"adult":51,"elderly":44},"countries":{"US":95},"first_public_year":"2022","gbp_per_sample_median":4.07,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_infection":14,"transplant_or_immunocompromised":23,"type2_diabetes":52},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs delayed FMT for MDRO decolonization in transplant recipients","interventions":["fmt"],"n_samples":95,"papers":[{"doi":"10.1126/scitranslmed.abo2750","pmcid":"PMC10821315","pmid":"37910603","title":"Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":51,"no_intervention":44},"sex":{"female":52,"male":43},"title":"PREMIX","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA728680","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA728680_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA728680.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA728680.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA728680.csv.gz"}},{"accession":"PRJEB36140","age_categories":{"unknown":93},"countries":{"NO":93},"first_public_year":"2020","gbp_per_sample_median":7.44,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ibs":66},"intervention_design":"randomized_controlled_trial","intervention_detail":"Fecal microbiota transplantation, REFIT trial, active FMT arm only","interventions":["fmt"],"n_samples":93,"papers":[{"doi":"10.1080/19490976.2020.1794263","pmcid":"PMC7583512","pmid":"32991818","title":"Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome."},{"doi":"10.1186/s12967-026-08269-w","pmcid":"PMC13505095","pmid":"42298631","title":"Cross-kingdom microbial associations characterize responsiveness to fecal microbiota transplantation in patients with irritable bowel syndrome."},{"doi":"10.1038/s41467-022-34405-3","pmcid":"PMC9649010","pmid":"36357393","title":"Faecal microbiome-based machine learning for multi-class disease diagnosis."},{"doi":"10.1186/s40168-023-01623-w","pmcid":"PMC10424414","pmid":"37580821","title":"Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans."},{"doi":"10.1080/19490976.2026.2634469","pmcid":"PMC12940132","pmid":"41741396","title":"Temporal dynamics of gut biosynthetic gene clusters link persistent colonization and engraftment in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome is mirrored by changes in gut microbiome","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB36140","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB36140_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB36140.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB36140.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB36140.csv.gz"}},{"accession":"PRJNA1163373","age_categories":{"unknown":93},"countries":{"US":93},"first_public_year":"2025","gbp_per_sample_median":10.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Intestinal microbiota transplant immediately following surgery","interventions":["fmt","surgery"],"n_samples":93,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Jahansouz IMT Trial","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1163373","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1163373_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1163373.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1163373.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1163373.csv.gz"}},{"accession":"PRJNA406958","age_categories":{"unknown":92},"countries":{},"first_public_year":"2017","gbp_per_sample_median":0.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":92},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT via capsules or colonoscopy for recurrent C. difficile infection","interventions":["fmt"],"n_samples":92,"papers":[{"doi":"10.3390/microorganisms11041078","pmcid":"PMC10143790","pmid":"37110500","title":"In Silico Analysis of Changes in Predicted Metabolic Capabilities of Intestinal Microbiota after Fecal Microbial Transplantation for Treatment of Recurrent Clostridioides difficile Infection."},{"doi":"10.1038/s41598-022-13313-y","pmcid":"PMC9163076","pmid":"35654877","title":"Metagenomic assembled plasmids of the human microbiome vary across disease cohorts."},{"doi":"10.1126/scitranslmed.abo2750","pmcid":"PMC10821315","pmid":"37910603","title":"Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement."}],"sample_intervention_arms":{"fmt":20},"sex":{},"title":"Microbiota of RCDI patients subjected to FMT by capsules or colonoscopy","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA406958","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA406958_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA406958.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA406958.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA406958.csv.gz"}},{"accession":"PRJNA715586","age_categories":{"adult":90},"countries":{"FR":90},"first_public_year":"2021","gbp_per_sample_median":4.47,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":90},"intervention_design":"single_arm_before_after","intervention_detail":"Autologous FMT after intensive chemotherapy and antibiotics in AML","interventions":["fmt"],"n_samples":90,"papers":[{"doi":"10.1038/s41467-021-23376-6","pmcid":"PMC8149453","pmid":"34035290","title":"Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients."}],"sample_intervention_arms":{},"sex":{},"title":"PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (ODYSSEE)","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA715586","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA715586_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA715586.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA715586.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA715586.csv.gz"}},{"accession":"PRJEB46777","age_categories":{"adult":89},"countries":{"NL":89},"first_public_year":"2022","gbp_per_sample_median":5.36,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT via nasoduodenal tube vs autologous (control) in UC, double-blind RCT","interventions":["fmt"],"n_samples":89,"papers":[{"doi":"10.1053/j.gastro.2015.03.045","pmcid":null,"pmid":"25836986","title":"Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis."},{"doi":"10.1038/s41591-022-01913-0","pmcid":"PMC9499871","pmid":"36109636","title":"Drivers and determinants of strain dynamics following fecal microbiota transplantation."},{"doi":"10.1186/s40168-023-01623-w","pmcid":"PMC10424414","pmid":"37580821","title":"Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal Microbiota Transplantation for Ulcerative Colitis.","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB46777","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46777_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB46777.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB46777.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46777.csv.gz"}},{"accession":"PRJDB9649","age_categories":{"unknown":88},"countries":{"CN":88},"first_public_year":"2022","gbp_per_sample_median":9.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT from healthy donors via mid-gut vs placebo for diabetic peripheral neuropathy","interventions":["fmt"],"n_samples":88,"papers":[{"doi":"10.1016/j.cmet.2023.06.010","pmcid":null,"pmid":"37451270","title":"Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota transplantation alleviates diabetes peripheral neuropathy","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB9649","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB9649_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB9649.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB9649.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB9649.csv.gz"}},{"accession":"PRJNA1322507","age_categories":{"adult":87},"countries":{"US":87},"first_public_year":"2026","gbp_per_sample_median":8.69,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":87},"intervention_design":"randomized_controlled_trial","intervention_detail":"15-strain LBP (MTC01) vs same-donor FMT, low/high dose","interventions":["fmt","live_biotherapeutic"],"n_samples":87,"papers":[{"doi":"10.1038/s41591-026-04442-2","pmcid":"PMC13444918","pmid":"42230754","title":"15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial."}],"sample_intervention_arms":{},"sex":{},"title":"Live biotherapeutic product MTC01 vs FMT","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1322507","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1322507_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1322507.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1322507.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1322507.csv.gz"}},{"accession":"PRJNA705895","age_categories":{"adult":87},"countries":{"US":87},"first_public_year":"2021","gbp_per_sample_median":8.13,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":58,"healthy_control":29},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from healthy donors to RCDI patients","interventions":["fmt"],"n_samples":87,"papers":[{"doi":"10.1371/journal.pone.0251590","pmcid":"PMC8274925","pmid":"34252073","title":"Identification and engraftment of new bacterial strains by shotgun metagenomic sequence analysis in patients with recurrent Clostridioides difficile infection before and after fecal microbiota transpl"},{"doi":"10.1016/j.gastha.2024.10.008","pmcid":"PMC11795084","pmid":"39911724","title":"Detection of Human Y Chromosome and the SRY Gene in Fecal Samples of Female Patients Following Fecal Microbiota Transplantation."},{"doi":"10.1093/infdis/jiae470","pmcid":"PMC12247820","pmid":"39316685","title":"Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."},{"doi":"10.1016/j.isci.2026.116025","pmcid":"PMC13213781","pmid":"42211136","title":"Cohesive modules of engraftment in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota of donors and RCDI patients before and after FMT","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA705895","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA705895_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA705895.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA705895.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA705895.csv.gz"}},{"accession":"PRJNA813736","age_categories":{"adult":87},"countries":{"IE":87},"first_public_year":"2022","gbp_per_sample_median":1.86,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":19,"healthy_control":48,"ulcerative_colitis":20},"intervention_design":"observational_with_procedure","intervention_detail":"Faecal microbiota transplant cohorts compared for plasmidome diversity restoration","interventions":["fmt"],"n_samples":87,"papers":[{"doi":"10.1038/s41598-022-13313-y","pmcid":"PMC9163076","pmid":"35654877","title":"Metagenomic assembled plasmids of the human microbiome vary across disease cohorts."}],"sample_intervention_arms":{},"sex":{"female":39,"male":41},"title":"Whole genome sequencing of the faecal microbiomes from healthy controls and patients with inflammatory bowel disease","trial_population_condition":"ibd_unspecified","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA813736","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA813736_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA813736.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA813736.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA813736.csv.gz"}},{"accession":"PRJNA637878","age_categories":{"adult":85},"countries":{"US":85},"first_public_year":"2021","gbp_per_sample_median":1.03,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":5,"healthy_control":10,"ibd_unspecified":4},"intervention_design":"unknown","intervention_detail":"FMT for recurrent C. difficile; donor strains tracked post-transplant in recipients","interventions":["fmt"],"n_samples":85,"papers":[{"doi":"10.1038/s41564-021-00966-0","pmcid":"PMC8993687","pmid":"34580445","title":"Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes."},{"doi":"10.1016/j.chom.2022.08.009","pmcid":"PMC9588646","pmid":"36099923","title":"Human gut microbiota stimulate defined innate immune responses that vary from phylum to strain."},{"doi":"10.1073/pnas.2215914120","pmcid":"PMC10041165","pmid":"36917674","title":"Species-specific CD4+ T cells enable prediction of mucosal immune phenotypes from microbiota composition."},{"doi":"10.1016/j.celrep.2026.117645","pmcid":"PMC13471986","pmid":"42412611","title":"Combining genotoxic gut bacterial strains increases tumor burden and accelerates onset in a germ-free mouse model of colon carcinogenesis."},{"doi":"10.1038/s41598-023-41128-y","pmcid":"PMC10465488","pmid":"37644161","title":"Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile."}],"sample_intervention_arms":{"fmt":60,"no_intervention":9},"sex":{},"title":"Precise quantification and tracking of gut bacterial strains following fecal transplantation demonstrates long-term stable engraftment and predicts outcome","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA637878","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA637878_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA637878.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA637878.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA637878.csv.gz"}},{"accession":"PRJEB75958","age_categories":{"adult":83,"elderly":1},"countries":{"ES":84},"first_public_year":"2024","gbp_per_sample_median":0.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_infection":84},"intervention_design":"randomized_controlled_trial","intervention_detail":"Weekly oral FMT capsules vs placebo for 8 weeks","interventions":["fmt"],"n_samples":84,"papers":[{"doi":"10.1038/s41467-021-21472-1","pmcid":"PMC7892558","pmid":"33602945","title":"Fecal microbiota transplantation in HIV: A pilot placebo-controlled study."},{"doi":"10.1186/s40168-024-01919-5","pmcid":"PMC11494993","pmid":"39438902","title":"Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers."}],"sample_intervention_arms":{"fmt":41,"no_intervention":27,"placebo":16},"sex":{"female":8,"male":73},"title":"REpeated Fecal microbiota REStoration in Hiv","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB75958","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB75958_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB75958.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB75958.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB75958.csv.gz"}},{"accession":"PRJNA1435194","age_categories":{"adult":84},"countries":{"NO":84},"first_public_year":"2026","gbp_per_sample_median":3.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in systemic sclerosis patients, sampled weeks 0, 2, 12","interventions":["fmt"],"n_samples":84,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"CYP3A activity in patients with systemic sclerosis before and after Fecal Microbiota Transplantation","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1435194","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1435194_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1435194.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1435194.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1435194.csv.gz"}},{"accession":"PRJEB64621","age_categories":{"unknown":83},"countries":{"NL":83},"first_public_year":"2023","gbp_per_sample_median":12.65,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":63},"intervention_design":"single_arm_before_after","intervention_detail":"FMT in recurrent C. difficile infection patients, before/after, with donor samples","interventions":["fmt"],"n_samples":83,"papers":[{"doi":"10.1186/s13073-024-01306-7","pmcid":"PMC10902993","pmid":"38419010","title":"Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":42},"sex":{},"title":"Faecal shotgun metagenomes of healthy stool donors from the Netherlands Donor Feces Bank and multiple recurrent Clostridioides difficile infection patients with long-term follow-up","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB64621","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64621_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB64621.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB64621.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64621.csv.gz"}},{"accession":"PRJNA1066476","age_categories":{"adult":83},"countries":{"CN":83},"first_public_year":"2024","gbp_per_sample_median":6.01,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ulcerative_colitis":75},"intervention_design":"single_arm_before_after","intervention_detail":"Capsulized fecal microbiota transplantation in active ulcerative colitis patients","interventions":["fmt"],"n_samples":83,"papers":[{"doi":"10.3389/fcimb.2022.1086885","pmcid":"PMC9849685","pmid":"36683707","title":"Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis."},{"doi":"10.1128/spectrum.04152-22","pmcid":"PMC10269780","pmid":"37093057","title":"Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation."}],"sample_intervention_arms":{"fmt":55,"no_intervention":28},"sex":{},"title":"Profiling the gut microbiome of patients with active ulcerative colitis received capsulized fecal microbiota transplantation","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1066476","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1066476_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1066476.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1066476.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1066476.csv.gz"}},{"accession":"PRJNA353598","age_categories":{"adult":10,"elderly":8,"unknown":65},"countries":{},"first_public_year":"2017","gbp_per_sample_median":6.74,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":24,"healthy_control":20},"intervention_design":"non_randomized_controlled","intervention_detail":"FMT vs vancomycin for recurrent C. difficile infection","interventions":["antibiotic","fmt"],"n_samples":83,"papers":[{"doi":"10.1136/gutjnl-2017-313952","pmcid":"PMC5868238","pmid":"28539351","title":"Bacteriophage transfer during faecal microbiota transplantation in <i>Clostridium difficile</i> infection is associated with treatment outcome."}],"sample_intervention_arms":{"fmt":1},"sex":{"female":11,"male":7},"title":"viral metagenome Metagenome","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA353598","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA353598_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA353598.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA353598.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA353598.csv.gz"}},{"accession":"PRJNA454892","age_categories":{"unknown":83},"countries":{"CA":83},"first_public_year":"2018","gbp_per_sample_median":0.03,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":57,"healthy_control":26},"intervention_design":"single_arm_before_after","intervention_detail":"FMT via colonoscopy for recurrent C. difficile infection","interventions":["fmt"],"n_samples":83,"papers":[{"doi":"10.1080/19490976.2019.1586037","pmcid":"PMC6867182","pmid":"30866714","title":"The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study."},{"doi":"10.1093/bioinformatics/btad236","pmcid":"PMC10311314","pmid":"37387148","title":"Bakdrive: identifying a minimum set of bacterial species driving interactions across multiple microbial communities."}],"sample_intervention_arms":{"fmt":38,"no_intervention":45},"sex":{},"title":"Shotgun metagenome library","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA454892","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA454892_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA454892.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA454892.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA454892.csv.gz"}},{"accession":"PRJNA1209112","age_categories":{"adult":80},"countries":{"US":80},"first_public_year":"2025","gbp_per_sample_median":2.9,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":80},"intervention_design":"single_arm_before_after","intervention_detail":"Oral encapsulated FMT from one of 3 healthy donors post-alloHCT","interventions":["fmt"],"n_samples":80,"papers":[{"doi":"10.1038/s41467-025-56375-y","pmcid":"PMC11762788","pmid":"39863610","title":"Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect."},{"doi":"10.1080/19490976.2025.2551882","pmcid":"PMC12396129","pmid":"40867077","title":"Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation."},{"doi":"10.1016/j.isci.2026.116025","pmcid":"PMC13213781","pmid":"42211136","title":"Cohesive modules of engraftment in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"FMT to prevent acute GVHD","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1209112","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1209112_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1209112.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1209112.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1209112.csv.gz"}},{"accession":"PRJEB46779","age_categories":{"unknown":79},"countries":{"NL":79},"first_public_year":"2022","gbp_per_sample_median":5.53,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_infection":79},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for ESBL-EB decolonization","interventions":["fmt"],"n_samples":79,"papers":[{"doi":"10.1186/s13104-018-3293-x","pmcid":"PMC5863815","pmid":"29566738","title":"Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study."},{"doi":"10.1038/s41591-022-01913-0","pmcid":"PMC9499871","pmid":"36109636","title":"Drivers and determinants of strain dynamics following fecal microbiota transplantation."},{"doi":"10.1186/s40168-023-01623-w","pmcid":"PMC10424414","pmid":"37580821","title":"Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal Microbiota Transplantation for Extended-Spectrum Beta Lactamase Carriers.","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB46779","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46779_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB46779.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB46779.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46779.csv.gz"}},{"accession":"PRJNA782533","age_categories":{"child":79},"countries":{"US":79},"first_public_year":"2021","gbp_per_sample_median":7.58,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":20,"neurological_psychiatric":52},"intervention_design":"single_arm_before_after","intervention_detail":"Microbiota Transfer Therapy (fecal microbiota transplant) in children with ASD","interventions":["fmt"],"n_samples":79,"papers":[{"doi":"10.3390/ijms232113481","pmcid":"PMC9654974","pmid":"36362265","title":"Shotgun Metagenomics Study Suggests Alteration in Sulfur Metabolism and Oxidative Stress in Children with Autism and Improvement after Microbiota Transfer Therapy."},{"doi":"10.1016/j.xcrm.2025.102516","pmcid":"PMC12866134","pmid":"41421350","title":"Integrative multi-omics reveals microbial genomic variants driving altered host-microbe interactions in autism spectrum disorder."},{"doi":"10.1136/gutjnl-2025-337280","pmcid":"PMC13151442","pmid":"41748159","title":"Bacterial genomic structural variations in children with autism serve as diagnostic biomarkers."}],"sample_intervention_arms":{"fmt":34,"no_intervention":18},"sex":{},"title":"Metagenomic study of the gut microbiome associated with autism spectrum disorders and their potential change after Microbiota Transfer Therapy","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA782533","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA782533_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA782533.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA782533.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA782533.csv.gz"}},{"accession":"PRJEB74426","age_categories":{"unknown":78},"countries":{"CN":78},"first_public_year":"2026","gbp_per_sample_median":10.99,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_disease":78},"intervention_design":"single_arm_before_after","intervention_detail":"FMT treatment in atopic dermatitis patients, pre/post sampling","interventions":["fmt"],"n_samples":78,"papers":[],"sample_intervention_arms":{"fmt":33,"placebo":24},"sex":{},"title":"Estimate the effect of FMT that treat AD","trial_population_condition":"allergy_or_atopy","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB74426","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB74426_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB74426.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB74426.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB74426.csv.gz"}},{"accession":"PRJEB56674","age_categories":{"adult":72},"countries":{"CA":72},"first_public_year":"2023","gbp_per_sample_median":4.22,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":72},"intervention_design":"non_randomized_controlled","intervention_detail":"Microbial consortium (MET-2) vs FMT for recurrent C. difficile infection","interventions":["fmt","live_biotherapeutic"],"n_samples":72,"papers":[{"doi":"10.1128/mbio.03482-22","pmcid":"PMC10506460","pmid":"37404011","title":"A microbial consortium alters intestinal Pseudomonadota and antimicrobial resistance genes in individuals with recurrent Clostridioides difficile infection."}],"sample_intervention_arms":{"fmt":14,"live_biotherapeutic":38,"no_intervention":20},"sex":{},"title":"Proteobacteria and antimicrobial resistant genes after microbial consortia","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB56674","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB56674_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB56674.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB56674.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB56674.csv.gz"}},{"accession":"PRJNA474024","age_categories":{"unknown":72},"countries":{"US":72},"first_public_year":"2019","gbp_per_sample_median":0.08,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ibd_unspecified":72},"intervention_design":"single_arm_before_after","intervention_detail":"Endoscopic FMT then oral capsule maintenance for 12 weeks","interventions":["fmt"],"n_samples":72,"papers":[{"doi":"10.1126/science.aau5238","pmcid":"PMC6543533","pmid":"30630933","title":"Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host adaptation in the gut."}],"sample_intervention_arms":{},"sex":{},"title":"Engraftment of Bacteroidetes species in a Fecal Microbiota Transplant study","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA474024","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA474024_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA474024.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA474024.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA474024.csv.gz"}},{"accession":"PRJNA673918","age_categories":{"adult":71},"countries":{"CN":71},"first_public_year":"2021","gbp_per_sample_median":7.25,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type2_diabetes":71},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation in T2DM patients","interventions":["fmt"],"n_samples":71,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Shorgun metagenomics of T2DM human gut microbes associated with FMT","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA673918","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA673918_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA673918.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA673918.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA673918.csv.gz"}},{"accession":"PRJNA928744","age_categories":{"adult":27,"elderly":44},"countries":{"CA":71},"first_public_year":"2023","gbp_per_sample_median":5.2,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":11,"other_cancer":60},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from healthy donor combined with anti-PD1 therapy in melanoma","interventions":["drug_therapy","fmt"],"n_samples":71,"papers":[{"doi":"10.1136/jitc-2025-012659","pmcid":"PMC12359429","pmid":"40759441","title":"Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial."},{"doi":"10.1016/j.chom.2024.10.006","pmcid":"PMC11629153","pmid":"39481388","title":"Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients."},{"doi":"10.1038/s41586-025-09249-8","pmcid":"PMC12390848","pmid":"40659786","title":"Microbiota-driven antitumour immunity mediated by dendritic cell migration."},{"doi":"10.1186/s40168-025-02249-w","pmcid":"PMC12590682","pmid":"41199348","title":"Accurate profiling of microbial communities for shotgun metagenomic sequencing with Meteor2."},{"doi":"10.34133/csbj.0065","pmcid":"PMC13173278","pmid":"42146906","title":"Ecological and Functional Stratification of the Stool Microbiome Predicts Response to Immune Checkpoint Inhibitors across Cancer Types."}],"sample_intervention_arms":{},"sex":{"female":20,"male":40},"title":"Gut microbiota composition of patients in MIMic cohort","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA928744","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA928744_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA928744.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA928744.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA928744.csv.gz"}},{"accession":"PRJNA1064467","age_categories":{"unknown":70},"countries":{"DE":70},"first_public_year":"2024","gbp_per_sample_median":3.77,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":35},"intervention_design":"observational_with_procedure","intervention_detail":"FMT from antibiotic-treated hospitalized patients into mice","interventions":["fmt"],"n_samples":70,"papers":[{"doi":"10.1038/s41467-024-47149-z","pmcid":"PMC10981692","pmid":"38555356","title":"Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung."}],"sample_intervention_arms":{},"sex":{},"title":"Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1064467","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1064467_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1064467.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1064467.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1064467.csv.gz"}},{"accession":"PRJNA961175","age_categories":{"unknown":69},"countries":{"US":69},"first_public_year":"2023","gbp_per_sample_median":6.3,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Healthy-donor fecal microbiota transplantation for refractory immune-related colitis","interventions":["fmt"],"n_samples":69,"papers":[{"doi":"10.1158/2326-6066.cir-23-0498","pmcid":"PMC10932930","pmid":"38108398","title":"Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation."},{"doi":"10.1084/jem.20232079","pmcid":"PMC11636624","pmid":"39666007","title":"Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis."}],"sample_intervention_arms":{"fmt":9,"no_intervention":5},"sex":{},"title":"Fecal microbiota profiling in patients with immune-related colitis","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA961175","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA961175_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA961175.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA961175.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA961175.csv.gz"}},{"accession":"PRJNA1121295","age_categories":{"unknown":68},"countries":{"FR":68},"first_public_year":"2024","gbp_per_sample_median":3.87,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":68},"intervention_design":"single_arm_before_after","intervention_detail":"Single dose FMT from healthy donor for CPE decolonization","interventions":["fmt"],"n_samples":68,"papers":[{"doi":"10.1016/j.jinf.2024.106216","pmcid":null,"pmid":"38964511","title":"Bacterial diversity and specific taxa are associated with decolonization of carbapenemase-producing enterobacterales after fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":9},"sex":{},"title":"FEDEX Study Fecal Metagenomes","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1121295","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1121295_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1121295.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1121295.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1121295.csv.gz"}},{"accession":"PRJNA647221","age_categories":{"adult":68},"countries":{},"first_public_year":"2024","gbp_per_sample_median":9.15,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":68},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation in ulcerative colitis patients","interventions":["fmt"],"n_samples":68,"papers":[{"doi":"10.5009/gnl210369","pmcid":"PMC9474483","pmid":"35975640","title":"Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea."}],"sample_intervention_arms":{},"sex":{},"title":"Before and after fecal microbiota transplantation in ulcerative colitis patients","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA647221","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA647221_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA647221.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA647221.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA647221.csv.gz"}},{"accession":"PRJNA1220173","age_categories":{"unknown":65},"countries":{"CA":65},"first_public_year":"2025","gbp_per_sample_median":6.02,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":4,"ulcerative_colitis":61},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT from single donor vs placebo in ulcerative colitis","interventions":["fmt"],"n_samples":65,"papers":[{"doi":"10.1038/s41467-025-58673-x","pmcid":"PMC11992129","pmid":"40216789","title":"Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise."}],"sample_intervention_arms":{"fmt":12,"placebo":24},"sex":{},"title":"Detecting microbial engraftment after FMT in patients with ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1220173","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1220173_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1220173.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1220173.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1220173.csv.gz"}},{"accession":"PRJNA1445352","age_categories":{"child":62},"countries":{"US":62},"first_public_year":"2026","gbp_per_sample_median":3.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"malnutrition":17,"neurological_psychiatric":45},"intervention_design":"randomized_controlled_trial","intervention_detail":"Microbiota transplant therapy with antibiotics and bowel cleansing pretreatment, RCT vs placebo","interventions":["antibiotic","bowel_preparation","fmt"],"n_samples":62,"papers":[{"doi":"10.21203/rs.3.rs-9930475/v1","pmcid":null,"pmid":null,"title":"Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms in Children with Pitt-Hopkins Syndrome: A Randomized Clinical Trial"}],"sample_intervention_arms":{"antibiotic":12,"fmt":15,"no_intervention":29,"placebo":6},"sex":{},"title":"Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms by Modulating Gut Microbiota in Children with Pitt-Hopkins Syndrome, A Rare Neurodevelopmental Disorder","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1445352","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1445352_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1445352.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1445352.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1445352.csv.gz"}},{"accession":"PRJNA1160779","age_categories":{"unknown":59},"countries":{"DK":59},"first_public_year":"2025","gbp_per_sample_median":15.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":59},"intervention_design":"single_arm_before_after","intervention_detail":"Single-donor faecal microbiota transplantation in PsA patients","interventions":["fmt"],"n_samples":59,"papers":[{"doi":"10.1002/art.43359","pmcid":"PMC12936901","pmid":"40814761","title":"Clinical Significance of Gut Microbiota Community Types for Long-Term Response to Fecal Microbiota Transplantation in Patients With Psoriatic Arthritis."}],"sample_intervention_arms":{},"sex":{},"title":"Flora Metagenome","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1160779","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1160779_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1160779.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1160779.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1160779.csv.gz"}},{"accession":"PRJNA768409","age_categories":{"unknown":59},"countries":{"US":59},"first_public_year":"2021","gbp_per_sample_median":22.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ulcerative_colitis":59},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation, 2-donor preparation, sampled pre- and week 4 post-FMT","interventions":["fmt"],"n_samples":59,"papers":[{"doi":"10.1053/j.gastro.2021.09.061","pmcid":"PMC8678328","pmid":"34606847","title":"Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation."}],"sample_intervention_arms":{"fmt":19,"no_intervention":20},"sex":{},"title":"Metagenomic sequencing of UC patients subjected to FMT and FMT-donors","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA768409","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA768409_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA768409.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA768409.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA768409.csv.gz"}},{"accession":"PRJNA1401743","age_categories":{"unknown":57},"countries":{"HK":57},"first_public_year":"2026","gbp_per_sample_median":7.9,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":57},"intervention_design":"single_arm_before_after","intervention_detail":"FMT in Crohn's disease patients, before/after sampling","interventions":["fmt"],"n_samples":57,"papers":[],"sample_intervention_arms":{"fmt":25},"sex":{},"title":"Fecal microbiome in Crohn's disease before and after FMT","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1401743","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1401743_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1401743.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1401743.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1401743.csv.gz"}},{"accession":"PRJNA1065951","age_categories":{"adult":56},"countries":{"CN":56},"first_public_year":"2024","gbp_per_sample_median":12.58,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"colorectal_cancer":7,"other_disease":35},"intervention_design":"single_arm_before_after","intervention_detail":"FMT capsules from healthy donors combined with nivolumab (anti-PD-1)","interventions":["drug_therapy","fmt"],"n_samples":56,"papers":[{"doi":"10.1136/jitc-2025-013823","pmcid":"PMC13034380","pmid":"41871875","title":"Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study."}],"sample_intervention_arms":{"fmt":46,"no_intervention":10},"sex":{},"title":"Fecal microbiota transplantation promotes immunotherapy sensitivity in refractory gastrointestinal cancer patients","trial_population_condition":"colorectal_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1065951","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1065951_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1065951.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1065951.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1065951.csv.gz"}},{"accession":"PRJNA763503","age_categories":{"unknown":56},"countries":{"RU":56},"first_public_year":"2021","gbp_per_sample_median":1.39,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":24,"healthy_control":5,"ulcerative_colitis":24},"intervention_design":"single_arm_before_after","intervention_detail":"FMT combined with anti-inflammatory therapy in CD/UC patients","interventions":["fmt"],"n_samples":56,"papers":[{"doi":"10.21203/rs.3.rs-999905/v1","pmcid":null,"pmid":null,"title":"Character of Microbial Engraftment Following the Fecal Microbiota Transplantation in Patients with Inflammatory Bowel Diseases"}],"sample_intervention_arms":{},"sex":{},"title":"Character of microbial engraftment following the fecal microbiota transplantation in patients with inflammatory bowel diseases","trial_population_condition":"ibd_unspecified","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA763503","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA763503_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA763503.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA763503.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA763503.csv.gz"}},{"accession":"PRJEB12357","age_categories":{"adult":55},"countries":{"NL":55},"first_public_year":"2016","gbp_per_sample_median":4.8,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"cardiometabolic_other":50,"healthy_control":5},"intervention_design":"randomized_controlled_trial","intervention_detail":"Allogenic (lean donor) vs autologous FMT via small intestinal infusion","interventions":["fmt"],"n_samples":55,"papers":[{"doi":"10.1053/j.gastro.2012.06.031","pmcid":null,"pmid":"22728514","title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome."},{"doi":"10.1126/science.aad8852","pmcid":null,"pmid":"27126044","title":"Durable coexistence of donor and recipient strains after fecal microbiota transplantation."},{"doi":"10.1038/s41522-018-0065-2","pmcid":"PMC6123480","pmid":"30210803","title":"GePMI: A statistical model for personal intestinal microbiome identification."},{"doi":"10.1089/crispr.2018.0046","pmcid":"PMC6390457","pmid":"30820491","title":"CRISPRs for Strain Tracking and Their Application to Microbiota Transplantation Data Analysis."},{"doi":"10.1038/s41467-020-19940-1","pmcid":"PMC7719190","pmid":"33277504","title":"Deciphering functional redundancy in the human microbiome."}],"sample_intervention_arms":{},"sex":{"male":55},"title":"Durable coexistence of donor and recipient strains after fecal microbiota transplantation","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB12357","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB12357_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB12357.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB12357.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB12357.csv.gz"}},{"accession":"PRJNA641975","age_categories":{"adolescent":55},"countries":{"HK":55},"first_public_year":"2020","gbp_per_sample_median":8.93,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"transplant_or_immunocompromised":55},"intervention_design":"single_arm_before_after","intervention_detail":"Four weekly doses of FMT for gut GvHD in a teenager","interventions":["fmt"],"n_samples":55,"papers":[{"doi":"10.1038/s41467-020-20240-x","pmcid":"PMC7782528","pmid":"33397897","title":"Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota transplantations reconstitute gut fungal and viral microbiota in graft-versus-host disease","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA641975","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA641975_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA641975.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA641975.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA641975.csv.gz"}},{"accession":"PRJNA1512161","age_categories":{"adult":54},"countries":{"ES":54},"first_public_year":"2026","gbp_per_sample_median":5.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT (EUTEGRA/MBK-01) vs fidaxomicin for recurrent C. difficile infection","interventions":["antibiotic","fmt"],"n_samples":54,"papers":[],"sample_intervention_arms":{"antibiotic":15,"fmt":12,"no_intervention":27},"sex":{},"title":"Fecal Microbiota Transplantation Achieves Greater Restoration of Microbiota Diversity and Higher Butyrate Production than Fidaxomicin","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1512161","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1512161_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1512161.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1512161.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1512161.csv.gz"}},{"accession":"PRJNA626062","age_categories":{"adult":54},"countries":{"CN":54},"first_public_year":"2020","gbp_per_sample_median":0.02,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":20,"type2_diabetes":34},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from healthy donors to 17 T2DM patients, 12-week follow-up","interventions":["fmt"],"n_samples":54,"papers":[{"doi":"10.3389/fcimb.2022.820367","pmcid":"PMC8990819","pmid":"35402293","title":"Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients."}],"sample_intervention_arms":{"fmt":34,"no_intervention":20},"sex":{},"title":"Fecal microbiota transplant therapy in type 2 diabetes patients.","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA626062","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA626062_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA626062.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA626062.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA626062.csv.gz"}},{"accession":"PRJNA693652","age_categories":{"adult":54},"countries":{},"first_public_year":"2022","gbp_per_sample_median":5.06,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":36},"intervention_design":"unknown","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile infection","interventions":["fmt"],"n_samples":54,"papers":[{"doi":"10.1053/j.gastro.2021.02.013","pmcid":"PMC8684800","pmid":"33577875","title":"Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation."}],"sample_intervention_arms":{"fmt":18},"sex":{},"title":"The intestinal bacteriomes and viromes of pationts with recurrent CDI","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA693652","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA693652_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA693652.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA693652.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA693652.csv.gz"}},{"accession":"PRJNA321058","age_categories":{"unknown":53},"countries":{"US":53},"first_public_year":"2016","gbp_per_sample_median":4.66,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":53},"intervention_design":"single_arm_before_after","intervention_detail":"Single FMT via colonoscopy from healthy donors to active CD patients","interventions":["fmt"],"n_samples":53,"papers":[{"doi":"10.3389/fmicb.2020.00932","pmcid":"PMC7248251","pmid":"32508773","title":"Impact of Microbiota Transplant on Resistome of Gut Microbiota in Gnotobiotic Piglets and Human Subjects."},{"doi":"10.1038/s41579-019-0213-6","pmcid":"PMC6759048","pmid":"31249397","title":"Microbial genes and pathways in inflammatory bowel disease."},{"doi":"10.1038/s41467-024-47272-x","pmcid":"PMC11009399","pmid":"38605009","title":"Plasmids in the human gut reveal neutral dispersal and recombination that is overpowered by inflammatory diseases."},{"doi":"10.1016/j.chom.2025.01.002","pmcid":"PMC12268991","pmid":"39947133","title":"A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA321058","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA321058_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA321058.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA321058.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA321058.csv.gz"}},{"accession":"PRJNA1262688","age_categories":{"unknown":52},"countries":{"HK":52},"first_public_year":"2025","gbp_per_sample_median":7.42,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"crohns_disease":50,"healthy_control":2},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation, pre- and post-FMT sampling","interventions":["fmt"],"n_samples":52,"papers":[],"sample_intervention_arms":{"fmt":25,"no_intervention":25},"sex":{},"title":"Fecal Microbiota Transplantation for CD cohort","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1262688","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1262688_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1262688.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1262688.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1262688.csv.gz"}},{"accession":"PRJNA1303742","age_categories":{"unknown":52},"countries":{"AU":52},"first_public_year":"2025","gbp_per_sample_median":3.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":52},"intervention_design":"observational_with_procedure","intervention_detail":"FMT preparation processing and stability evaluation","interventions":["fmt"],"n_samples":52,"papers":[{"doi":"10.1101/2025.09.02.673862","pmcid":null,"pmid":null,"title":"Stability and Processing Impacts on Faecal Microbiota Transplant Products: An Integrated Metagenomic-Culturomic Analysis"}],"sample_intervention_arms":{},"sex":{},"title":"Impact of processing and stability on FMT composition","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1303742","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1303742_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1303742.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1303742.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1303742.csv.gz"}},{"accession":"PRJNA684000","age_categories":{"unknown":51},"countries":{"CA":51},"first_public_year":"2020","gbp_per_sample_median":0.02,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":34,"healthy_control":17},"intervention_design":"observational_with_procedure","intervention_detail":"FMT donor-recipient analysis for recurrent C. diff infection","interventions":["fmt"],"n_samples":51,"papers":[{"doi":"10.1038/s41598-021-82644-z","pmcid":"PMC7895960","pmid":"33608575","title":"Author Correction: The trans-kingdom battle between donor and recipient gut microbiome influences fecal microbiota transplantation outcome."}],"sample_intervention_arms":{"fmt":17,"no_intervention":34},"sex":{},"title":"Fecal Microbiota Transplantation Donor and Recipient Analysis","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA684000","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA684000_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA684000.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA684000.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA684000.csv.gz"}},{"accession":"PRJNA1184021","age_categories":{"adult":49},"countries":{"DK":49},"first_public_year":"2025","gbp_per_sample_median":17.57,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":13,"neurological_psychiatric":36},"intervention_design":"single_arm_before_after","intervention_detail":"Single FMT from healthy donors, oral capsules or rectal enema, in AN","interventions":["fmt"],"n_samples":49,"papers":[{"doi":"10.1038/s41467-026-68455-8","pmcid":"PMC12913639","pmid":"41535289","title":"Impact of a single fecal microbiome transplantation in adult women with anorexia nervosa: an open-label feasibility pilot trial."}],"sample_intervention_arms":{"fmt":18},"sex":{"female":36},"title":"FMT trial","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1184021","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1184021_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1184021.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1184021.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1184021.csv.gz"}},{"accession":"PRJNA1243589","age_categories":{"unknown":48},"countries":{"CN":48},"first_public_year":"2025","gbp_per_sample_median":1.72,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"obesity":48},"intervention_design":"single_arm_before_after","intervention_detail":"Three biweekly FMT sessions via nasojejunal tube","interventions":["fmt"],"n_samples":48,"papers":[{"doi":"10.1128/aem.00120-25","pmcid":"PMC12285249","pmid":"40464558","title":"Donor-derived microbial engraftment and gut microbiota shifts associated with weight loss following fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Metagenomic Sequencing of Donor and Recipient Gut Microbiota in Fecal Microbiota Transplantation for Overweight and Obese Individuals","trial_population_condition":"obesity","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1243589","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1243589_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1243589.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1243589.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1243589.csv.gz"}},{"accession":"PRJNA1484494","age_categories":{"child":48},"countries":{"CN":48},"first_public_year":"2026","gbp_per_sample_median":1.84,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":48},"intervention_design":"non_randomized_controlled","intervention_detail":"FMT vs ketogenic diet in children with ASD","interventions":["diet_intervention","fmt"],"n_samples":48,"papers":[{"doi":"10.1186/s12888-026-08547-3","pmcid":"PMC13536674","pmid":"42687165","title":"Comparison of clinical efficacy and gut microbiota characteristics in children with ASD treated with fecal microbiota transplantation and ketogenic diet."}],"sample_intervention_arms":{"diet_intervention":24,"fmt":24},"sex":{},"title":"FMT-KD-Metagenomic raw data Metagenome","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1484494","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1484494_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1484494.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1484494.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1484494.csv.gz"}},{"accession":"PRJNA499081","age_categories":{"adult":46},"countries":{"NL":46},"first_public_year":"2019","gbp_per_sample_median":1.3,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"cardiometabolic_other":41,"healthy_control":5},"intervention_design":"randomized_controlled_trial","intervention_detail":"Healthy-donor stool FMT vs self-stool (autologous) control transplant","interventions":["fmt"],"n_samples":46,"papers":[{"doi":"10.1080/19490976.2021.1897217","pmcid":"PMC8023239","pmid":"33794724","title":"Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome."}],"sample_intervention_arms":{"fmt":27,"placebo":14},"sex":{"male":46},"title":"Gut bacteriophage community of metabolic syndrome subjects during fecal microbial transplant","trial_population_condition":"cardiometabolic_other","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA499081","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA499081_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA499081.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA499081.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA499081.csv.gz"}},{"accession":"PRJNA1055134","age_categories":{"unknown":45},"countries":{"US":45},"first_public_year":"2024","gbp_per_sample_median":0.11,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":45},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation in recurrent C. difficile infection patients","interventions":["fmt"],"n_samples":45,"papers":[{"doi":"10.1128/msphere.00706-24","pmcid":"PMC11520286","pmid":"39377587","title":"Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent <i>Clostridioides difficile</i> infection."},{"doi":"10.1080/29933935.2026.2648346","pmcid":"PMC13034631","pmid":"41918984","title":"Successful fecal microbiota transplants in post-antibiotic treated recurrent <i>Clostridioides difficile</i> patients induce acylcarnitine and sphingolipid lipidomic shifts."},{"doi":"10.1093/bib/bbag389","pmcid":"PMC13380309","pmid":"42470694","title":"Hierarchical Multi-Omics Trajectory Prediction for fecal microbiota transplantation: a novel machine learning framework for small-sample longitudinal multi-omics integration."}],"sample_intervention_arms":{"fmt":29,"no_intervention":16},"sex":{"female":33,"male":12},"title":"FMT stool metagenomics for rCDI","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1055134","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1055134_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1055134.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1055134.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1055134.csv.gz"}},{"accession":"PRJNA643802","age_categories":{"adult":45},"countries":{"IT":45},"first_public_year":"2020","gbp_per_sample_median":2.89,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":2,"other_cancer":26,"other_disease":17},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo FMT for TKI-induced diarrhoea in RCC patients","interventions":["fmt"],"n_samples":45,"papers":[{"doi":"10.1038/s41467-020-18127-y","pmcid":"PMC7455693","pmid":"32859933","title":"Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":32},"sex":{},"title":"FMT for diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA643802","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643802_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA643802.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA643802.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA643802.csv.gz"}},{"accession":"PRJNA1263159","age_categories":{"unknown":42},"countries":{"HK":42},"first_public_year":"2025","gbp_per_sample_median":4.56,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":36},"intervention_design":"single_arm_before_after","intervention_detail":"FMT in CDI recipients, pre- and post-FMT, with donor samples","interventions":["fmt"],"n_samples":42,"papers":[],"sample_intervention_arms":{"fmt":17,"no_intervention":25},"sex":{},"title":"Fecal Microbiota Transplantation for CDI cohort","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1263159","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1263159_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1263159.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1263159.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1263159.csv.gz"}},{"accession":"PRJNA678737","age_categories":{"unknown":42},"countries":{"IL":42},"first_public_year":"2021","gbp_per_sample_median":4.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":23},"intervention_design":"single_arm_before_after","intervention_detail":"FMT with anti-PD-1 re-induction in refractory metastatic melanoma, phase I trial","interventions":["fmt"],"n_samples":42,"papers":[{"doi":"10.1186/s12866-021-02312-0","pmcid":"PMC8454007","pmid":"34544375","title":"Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy."},{"doi":"10.1126/science.aaz7015","pmcid":"PMC8970537","pmid":"34941392","title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response."},{"doi":"10.1128/msystems.01023-22","pmcid":"PMC10134792","pmid":"36809182","title":"Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy."},{"doi":"10.1038/s41522-023-00421-4","pmcid":"PMC10400536","pmid":"37537181","title":"Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms."},{"doi":"10.1186/s13073-024-01285-9","pmcid":"PMC10799412","pmid":"38243343","title":"Gut microbiome for predicting immune checkpoint blockade-associated adverse events."}],"sample_intervention_arms":{"drug_therapy":23},"sex":{},"title":"Fecal microbiota transplantation modulates immunotherapy response in refractory metastatic melanoma patients","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA678737","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678737_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA678737.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA678737.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA678737.csv.gz"}},{"accession":"PRJEB80556","age_categories":{"adult":41},"countries":{"DK":41},"first_public_year":"2025","gbp_per_sample_median":3.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ibd_or_gi_disease":29},"intervention_design":"single_arm_before_after","intervention_detail":"FMT via enema from IPAA donor for chronic pouchitis","interventions":["fmt"],"n_samples":41,"papers":[{"doi":"10.1080/19490976.2025.2510464","pmcid":"PMC12118383","pmid":"40413728","title":"Fecal microbiota transplantation from a healthy pouch donor for chronic pouchitis: a proof-of-concept study."}],"sample_intervention_arms":{"fmt":29,"no_intervention":12},"sex":{},"title":"MicroPouch_NP","trial_population_condition":"ibd_or_gi_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB80556","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB80556_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB80556.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB80556.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB80556.csv.gz"}},{"accession":"PRJNA285502","age_categories":{"adult":41},"countries":{"US":41},"first_public_year":"2017","gbp_per_sample_median":4.25,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":41},"intervention_design":"single_arm_before_after","intervention_detail":"Single colonoscopic FMT administration in UC patients","interventions":["fmt"],"n_samples":41,"papers":[{"doi":"10.1371/journal.pone.0133925","pmcid":"PMC4544847","pmid":"26288277","title":"Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota transplantation (FMT) for ulcerative colitis","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA285502","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA285502_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA285502.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA285502.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA285502.csv.gz"}},{"accession":"PRJNA525458","age_categories":{"adolescent":15,"adult":4,"child":14,"infant":7},"countries":{},"first_public_year":"2020","gbp_per_sample_median":1.28,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":31,"healthy_control":9},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile in children","interventions":["fmt"],"n_samples":40,"papers":[{"doi":"10.1093/ofid/ofz379","pmcid":"PMC6790402","pmid":"31660343","title":"Fecal Transplant in Children With Clostridioides difficile Gives Sustained Reduction in Antimicrobial Resistance and Potential Pathogen Burden."},{"doi":"10.1038/s41598-023-41128-y","pmcid":"PMC10465488","pmid":"37644161","title":"Identification of donor Bacteroides vulgatus genes encoding proteins that correlate with early colonization following fecal transplant of patients with recurrent Clostridium difficile."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"no_intervention":9},"sex":{},"title":"Fecal transplant in children with Clostridioides difficile","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA525458","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA525458_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA525458.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA525458.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA525458.csv.gz"}},{"accession":"PRJNA851177","age_categories":{"adult":40},"countries":{"AU":40},"first_public_year":"2023","gbp_per_sample_median":5.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":40},"intervention_design":"randomized_controlled_trial","intervention_detail":"4 weeks low-dose erythromycin or azithromycin in healthy adults; FMT of erythromycin-exposed mouse microbiota into germ-free mice","interventions":["fmt"],"n_samples":40,"papers":[{"doi":"10.1128/spectrum.00831-23","pmcid":"PMC10433835","pmid":"37347185","title":"The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic Control."}],"sample_intervention_arms":{"antibiotic":40},"sex":{},"title":"Alteration of the gut microbiome through long-term macrolide therapy and associated changes in systemic immune and metabolic regulation","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA851177","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA851177_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA851177.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA851177.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA851177.csv.gz"}},{"accession":"PRJEB97162","age_categories":{"adult":36,"elderly":3},"countries":{"CH":39},"first_public_year":"2025","gbp_per_sample_median":1.42,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":39},"intervention_design":"single_arm_before_after","intervention_detail":"FMT capsules for recurrent C. difficile infection","interventions":["fmt"],"n_samples":39,"papers":[{"doi":"10.1101/2025.10.09.681403","pmcid":null,"pmid":null,"title":"Engraftment of donor phageome via fecal microbiota transplantation in recurrent  C. difficile  infection: a prospective observational study"}],"sample_intervention_arms":{"fmt":6,"no_intervention":33},"sex":{"female":6,"male":33},"title":"Engraftment of donor phageome via fecal microbiota transplantation in recurrent C. difficile infection","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB97162","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB97162_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB97162.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB97162.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB97162.csv.gz"}},{"accession":"PRJNA833152","age_categories":{"adolescent":38},"countries":{"CN":38},"first_public_year":"2022","gbp_per_sample_median":9.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"type1_diabetes":38},"intervention_design":"single_arm_before_after","intervention_detail":"One to three rounds of fecal microbiota transplantation","interventions":["fmt"],"n_samples":38,"papers":[{"doi":"10.3389/fimmu.2022.930872","pmcid":"PMC9414079","pmid":"36032108","title":"Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus."}],"sample_intervention_arms":{"fmt":6,"no_intervention":2},"sex":{"male":38},"title":"Fecal Microbiota Transplantation Treatment of Autoimmune-mediated Type 1 Diabetes Mellitus","trial_population_condition":"type1_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA833152","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA833152_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA833152.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA833152.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA833152.csv.gz"}},{"accession":"PRJNA904790","age_categories":{"unknown":38},"countries":{"US":38},"first_public_year":"2023","gbp_per_sample_median":1.21,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"obesity":38},"intervention_design":"randomized_controlled_trial","intervention_detail":"FMT vs placebo in obese patients, 4 weeks","interventions":["fmt"],"n_samples":38,"papers":[{"doi":"10.3390/nu14245200","pmcid":"PMC9785599","pmid":"36558359","title":"Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans."}],"sample_intervention_arms":{"fmt":22,"placebo":16},"sex":{},"title":"Impact of fecal microbiota transplantation on gut bacterial bile acid metabolism in humans","trial_population_condition":"obesity","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA904790","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA904790_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA904790.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA904790.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA904790.csv.gz"}},{"accession":"PRJEB58222","age_categories":{"adult":37},"countries":{"DE":37},"first_public_year":"2023","gbp_per_sample_median":9.63,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_cancer":37},"intervention_design":"unknown","intervention_detail":"FMT, tryptophan diet manipulation, oral 3-IAA, chemotherapy in mouse models; human cohorts observed","interventions":["diet_intervention","dietary_supplement","drug_therapy","fmt"],"n_samples":37,"papers":[{"doi":"10.1038/s41586-023-05728-y","pmcid":"PMC9977685","pmid":"36813961","title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","trial_population_condition":"other_cancer","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB58222","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58222_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB58222.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB58222.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB58222.csv.gz"}},{"accession":"PRJNA764525","age_categories":{"unknown":37},"countries":{"IL":37},"first_public_year":"2021","gbp_per_sample_median":0.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"autoimmune_inflammatory":37},"intervention_design":"observational_with_procedure","intervention_detail":"Fecal microbiota transplantation for graft-versus-host-disease, donor/recipient stool screening","interventions":["fmt"],"n_samples":37,"papers":[{"doi":"10.1182/bloodadvances.2021005110","pmcid":"PMC8791595","pmid":"34644375","title":"Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis."}],"sample_intervention_arms":{},"sex":{},"title":"Bloodstream infections' origins following fecal microbiota transplantation: a strain-level analysis","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA764525","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA764525_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA764525.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA764525.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA764525.csv.gz"}},{"accession":"PRJNA773237","age_categories":{"unknown":36},"countries":{"CN":36},"first_public_year":"2025","gbp_per_sample_median":5.9,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"ibs":36},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for irritable bowel syndrome","interventions":["fmt"],"n_samples":36,"papers":[],"sample_intervention_arms":{"fmt":18,"no_intervention":18},"sex":{},"title":"Metagenomic Sequencing","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA773237","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA773237_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA773237.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA773237.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA773237.csv.gz"}},{"accession":"PRJEB64567","age_categories":{"infant":14,"neonate":14,"unknown":7},"countries":{"FI":35},"first_public_year":"2023","gbp_per_sample_median":3.26,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"intervention_cohort":28,"pregnancy_postpartum":7},"intervention_design":"single_arm_before_after","intervention_detail":"Single oral dose maternal fecal microbiota transplant to CS-born infants","interventions":["fmt"],"n_samples":35,"papers":[{"doi":"10.1016/j.cell.2020.08.047","pmcid":null,"pmid":"33007265","title":"Maternal Fecal Microbiota Transplantation in Cesarean-Born Infants Rapidly Restores Normal Gut Microbial Development: A Proof-of-Concept Study."}],"sample_intervention_arms":{"fmt":28,"no_intervention":7},"sex":{},"title":"Maternal FMT in Cesarean-Born Infants - WGS sequencing of infants (1w to 1year) and maternal fecal samples","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB64567","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64567_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB64567.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB64567.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB64567.csv.gz"}},{"accession":"PRJNA765331","age_categories":{"child":35},"countries":{"US":35},"first_public_year":"2022","gbp_per_sample_median":10.37,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":35},"intervention_design":"unknown","intervention_detail":"FMT with adult donor material after SOC antibiotic therapy for pediatric CDI","interventions":["fmt"],"n_samples":35,"papers":[{"doi":"10.1038/s41522-023-00421-4","pmcid":"PMC10400536","pmid":"37537181","title":"Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms."}],"sample_intervention_arms":{"fmt":21},"sex":{},"title":"stool microbiome of pediatric CDI patients receiving FMT procedure with adult donor material","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA765331","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA765331_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA765331.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA765331.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA765331.csv.gz"}},{"accession":"PRJNA1312275","age_categories":{"unknown":34},"countries":{"CN":34},"first_public_year":"2025","gbp_per_sample_median":5.54,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Simulated FMT therapy in bumblebee model organism intestinal samples","interventions":["fmt"],"n_samples":34,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Constipation - Model Organism Research","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1312275","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1312275_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1312275.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1312275.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1312275.csv.gz"}},{"accession":"PRJNA628604","age_categories":{"adult":17,"elderly":10,"unknown":6},"countries":{"IL":33},"first_public_year":"2020","gbp_per_sample_median":4.31,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":6,"other_infection":27},"intervention_design":"single_arm_before_after","intervention_detail":"Oral capsulized FMT for 2 days to eradicate CPE carriage","interventions":["fmt"],"n_samples":33,"papers":[{"doi":"10.1093/cid/ciaa737","pmcid":null,"pmid":"32511695","title":"Oral capsulized Fecal microbiota transplantation for eradication of carbapenemase-producing Enterobacteriaceae colonization with a metagenomic perspective."},{"doi":"10.1126/scitranslmed.abo2750","pmcid":"PMC10821315","pmid":"37910603","title":"Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":27,"no_intervention":6},"sex":{},"title":"Oral capsulized Fecal microbiota transplantation for eradication of carbapenemase-producing Enterobacteriaceae colonization with a metagenomic perspective","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA628604","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA628604_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA628604.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA628604.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA628604.csv.gz"}},{"accession":"PRJNA734321","age_categories":{"unknown":33},"countries":{},"first_public_year":"2021","gbp_per_sample_median":2.72,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":5,"other_disease":28},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplant in mouse model of chronic multisymptom illness","interventions":["fmt"],"n_samples":33,"papers":[{"doi":"10.1038/s42003-022-03494-7","pmcid":"PMC9174162","pmid":"35672382","title":"Host gut resistome in Gulf War chronic multisymptom illness correlates with persistent inflammation."}],"sample_intervention_arms":{},"sex":{},"title":"Mouse gut metagenome in Gulf War Illness","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA734321","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA734321_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA734321.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA734321.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA734321.csv.gz"}},{"accession":"PRJNA929645","age_categories":{"unknown":32},"countries":{},"first_public_year":"2024","gbp_per_sample_median":11.48,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":32},"intervention_design":"single_arm_before_after","intervention_detail":"Washed microbiota transplantation (WMT) in UC patients","interventions":["fmt"],"n_samples":32,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Microbiota Genome sequencing","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA929645","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA929645_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA929645.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA929645.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA929645.csv.gz"}},{"accession":"PRJEB124243","age_categories":{"adult":31},"countries":{"FR":31},"first_public_year":"2026","gbp_per_sample_median":7.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Antibiotics then FMT for C. difficile infection, sampled before/after","interventions":["fmt"],"n_samples":31,"papers":[],"sample_intervention_arms":{"fmt":11},"sex":{},"title":"COSMIC project - Shotgun metagenomics of FMT samples","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB124243","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB124243_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB124243.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB124243.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB124243.csv.gz"}},{"accession":"PRJEB50699","age_categories":{"unknown":31},"countries":{},"first_public_year":"2022","gbp_per_sample_median":15.45,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":31},"intervention_design":"randomized_controlled_trial","intervention_detail":"Lyophilised oral FMT donor samples, double-blind RCT in ulcerative colitis","interventions":["fmt"],"n_samples":31,"papers":[{"doi":"10.1128/msystems.00746-24","pmcid":"PMC11406951","pmid":"39136455","title":"Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling."},{"doi":"10.1371/journal.pcbi.1013470","pmcid":"PMC12507277","pmid":"40934284","title":"kMermaid: Ultrafast metagenomic read assignment to protein clusters by hashing of amino acid k-mer frequencies."},{"doi":"10.1038/s41467-024-53454-4","pmcid":"PMC11487140","pmid":"39420033","title":"The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission."},{"doi":"10.1128/msystems.00991-25","pmcid":"PMC12542657","pmid":"40952001","title":"Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis."}],"sample_intervention_arms":{},"sex":{},"title":"Donor samples from Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS) study shotgun","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB50699","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB50699_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB50699.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB50699.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB50699.csv.gz"}},{"accession":"PRJNA1201226","age_categories":{"unknown":30},"countries":{"US":30},"first_public_year":"2026","gbp_per_sample_median":7.53,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"other_disease":30},"intervention_design":"observational_with_procedure","intervention_detail":"Upfront FMT for immunotherapy-induced colitis","interventions":["fmt"],"n_samples":30,"papers":[{"doi":"10.1016/j.xcrm.2026.103044","pmcid":null,"pmid":"42735684","title":"First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-mediated diarrhea and colitis."},{"doi":"10.21203/rs.3.rs-5455153/v1","pmcid":null,"pmid":null,"title":"Upfront fecal microbiota transplantation for the management of immune checkpoint inhibitor mediated diarrhea and colitis"}],"sample_intervention_arms":{"fmt":17,"no_intervention":8},"sex":{},"title":"Upfront fecal microbiota transplantation (FMT) for the management of immunotherapy colitis","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1201226","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1201226_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1201226.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1201226.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1201226.csv.gz"}},{"accession":"PRJEB39023","age_categories":{"unknown":27},"countries":{"US":27},"first_public_year":"2020","gbp_per_sample_median":8.24,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"gi_infection_or_diarrhoea":19,"healthy_control":8},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile infection","interventions":["fmt"],"n_samples":27,"papers":[{"doi":"10.1371/journal.pone.0081330","pmcid":"PMC3841263","pmid":"24303043","title":"Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection."},{"doi":"10.1016/j.cgh.2013.12.032","pmcid":null,"pmid":"24440222","title":"Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection."},{"doi":"10.1186/s40168-022-01251-w","pmcid":"PMC8951724","pmid":"35337386","title":"Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation."},{"doi":"10.1080/19490976.2022.2135963","pmcid":"PMC9621045","pmid":"36289064","title":"Functional profile of host microbiome indicates Clostridioides difficile infection."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":11,"no_intervention":8},"sex":{},"title":"Treatment of recurrent Clostridioides difficile infection with Fecal Microbiota Transplantation","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB39023","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB39023_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB39023.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB39023.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB39023.csv.gz"}},{"accession":"PRJNA349197","age_categories":{"adult":27},"countries":{},"first_public_year":"2017","gbp_per_sample_median":3.13,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":27},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for CDAD in HCT recipients","interventions":["fmt"],"n_samples":27,"papers":[{"doi":"10.1371/journal.pone.0182585","pmcid":"PMC5565110","pmid":"28827811","title":"Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{"female":15,"male":1},"title":"Metagenomics of clostridium difficile infection in hematopoietic stem cell recipients","trial_population_condition":"transplant_or_immunocompromised","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA349197","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA349197_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA349197.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA349197.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA349197.csv.gz"}},{"accession":"PRJEB35738","age_categories":{"unknown":26},"countries":{"KR":26},"first_public_year":"2020","gbp_per_sample_median":6.02,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":26},"intervention_design":"observational_with_procedure","intervention_detail":"FMT in CDI patients (secondary/public datasets, post-FMT samples analysed)","interventions":["fmt"],"n_samples":26,"papers":[{"doi":"10.1038/s41598-020-74090-0","pmcid":"PMC7573688","pmid":"33077744","title":"Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors."},{"doi":"10.1038/s41598-023-48221-2","pmcid":"PMC10684531","pmid":"38017092","title":"Comparative analyses of the faecal resistome against β-lactam and quinolone antibiotics in humans and livestock using metagenomic sequencing."},{"doi":"10.1080/19490976.2022.2135963","pmcid":"PMC9621045","pmid":"36289064","title":"Functional profile of host microbiome indicates Clostridioides difficile infection."}],"sample_intervention_arms":{},"sex":{},"title":"Clostridium difficile infection patient microbiome","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB35738","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35738_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB35738.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB35738.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB35738.csv.gz"}},{"accession":"PRJEB46780","age_categories":{"unknown":26},"countries":{"AU":26},"first_public_year":"2022","gbp_per_sample_median":3.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":2},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile infection or ulcerative colitis","interventions":["fmt"],"n_samples":26,"papers":[{"doi":"10.1038/s41591-022-01913-0","pmcid":"PMC9499871","pmid":"36109636","title":"Drivers and determinants of strain dynamics following fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":24},"sex":{},"title":"Fecal Microbiota Transplantation for Ulcerative Colitis and C. difficile Infection.","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB46780","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46780_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB46780.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB46780.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB46780.csv.gz"}},{"accession":"PRJNA1431449","age_categories":{"adult":26},"countries":{"US":26},"first_public_year":"2026","gbp_per_sample_median":5.87,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"allergy_or_atopy":26},"intervention_design":"single_arm_before_after","intervention_detail":"Oral encapsulated fecal microbiota transplantation in peanut allergy patients","interventions":["fmt"],"n_samples":26,"papers":[{"doi":"10.1126/scitranslmed.aee3263","pmcid":"PMC13591560","pmid":"42555752","title":"Fecal microbiome transplant in food allergy in humans and mice identifies a role for bile acid metabolites in oral tolerance."}],"sample_intervention_arms":{"fmt":13,"no_intervention":13},"sex":{"female":14,"male":12},"title":"Fecal Microbiome Transplant in Food Allergy Identifies a Role for Bile Acid Metabolites in Oral Tolerance","trial_population_condition":"allergy_or_atopy","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1431449","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1431449_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1431449.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1431449.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1431449.csv.gz"}},{"accession":"PRJNA420371","age_categories":{"unknown":26},"countries":{"US":26},"first_public_year":"2018","gbp_per_sample_median":5.86,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"unknown","intervention_detail":"Fecal microbiota transplantation from donor to CDI recipient","interventions":["fmt"],"n_samples":26,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"donor-recipient fecal metagenome analysis in C difficicle patient undergoing FMT","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA420371","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA420371_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA420371.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA420371.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA420371.csv.gz"}},{"accession":"PRJNA1284285","age_categories":{"adult":25},"countries":{"CN":25},"first_public_year":"2025","gbp_per_sample_median":6.9,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":25},"intervention_design":"single_arm_before_after","intervention_detail":"FMT via nasojejunal tube, 3 consecutive days, pilot trial","interventions":["fmt"],"n_samples":25,"papers":[{"doi":"10.4014/jmb.2509.09029","pmcid":"PMC12790986","pmid":"41466105","title":"Pilot Clinical Trial of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease."}],"sample_intervention_arms":{"fmt":24},"sex":{},"title":"Fecal microbiota transplantation for Parkinson's patients with constipation A pilot clinical trial","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1284285","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1284285_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1284285.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1284285.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1284285.csv.gz"}},{"accession":"PRJNA386502","age_categories":{"unknown":25},"countries":{"US":25},"first_public_year":"2017","gbp_per_sample_median":8.35,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"type2_diabetes":25},"intervention_design":"single_arm_before_after","intervention_detail":"Faecal microbiota transplantation in pre-diabetic patients","interventions":["fmt"],"n_samples":25,"papers":[],"sample_intervention_arms":{"fmt":12,"no_intervention":12},"sex":{},"title":"Pre-Diabetic FMT","trial_population_condition":"type2_diabetes","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA386502","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA386502_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA386502.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA386502.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA386502.csv.gz"}},{"accession":"PRJNA1069244","age_categories":{"unknown":22},"countries":{"CN":22},"first_public_year":"2024","gbp_per_sample_median":13.85,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":22},"intervention_design":"single_arm_before_after","intervention_detail":"Washed microbiota transplantation (WMT), single-arm, sampled before/3 months after","interventions":["fmt"],"n_samples":22,"papers":[{"doi":"10.3748/wjg.v30.i11.1572","pmcid":"PMC11008410","pmid":"38617453","title":"Washed microbiota transplantation for Crohn's disease: A metagenomic, metatranscriptomic, and metabolomic-based study."}],"sample_intervention_arms":{},"sex":{},"title":"metagenome and metatranscriptome changes in Crohn's disease patients before and after WMT","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1069244","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1069244_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1069244.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1069244.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1069244.csv.gz"}},{"accession":"PRJNA1101882","age_categories":{"adult":20},"countries":{"US":20},"first_public_year":"2025","gbp_per_sample_median":13.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Fecal microbiota transplantation for recurrent C. diff / IBD, strain tracking","interventions":["fmt"],"n_samples":20,"papers":[{"doi":"10.1038/s41564-025-02164-8","pmcid":"PMC12967305","pmid":"41125958","title":"Long-read metagenomics for strain tracking after faecal microbiota transplant."}],"sample_intervention_arms":{"fmt":7,"no_intervention":6},"sex":{},"title":"Long-read metagenomics for strain tracking after fecal microbiota transplant","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1101882","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1101882_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1101882.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1101882.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1101882.csv.gz"}},{"accession":"PRJNA1370667","age_categories":{"unknown":20},"countries":{"CA":20},"first_public_year":"2025","gbp_per_sample_median":63.48,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT via LFMT or LSFF approaches, donors and recipients sampled before/after","interventions":["fmt"],"n_samples":20,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Human gut microbiome","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1370667","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1370667_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1370667.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1370667.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1370667.csv.gz"}},{"accession":"PRJNA832701","age_categories":{"adult":19},"countries":{"US":19},"first_public_year":"2023","gbp_per_sample_median":0.94,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Fecal transfer of depressed patients'/controls' microbiomes into germ-free-like mice","interventions":["fmt"],"n_samples":19,"papers":[{"doi":"10.1186/s40168-022-01428-3","pmcid":"PMC10142784","pmid":"37106375","title":"Th17 cells sense microbiome to promote depressive-like behaviors."}],"sample_intervention_arms":{},"sex":{},"title":"Microbiomes of depressed patients and healthy controls, and of the recipient mice","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA832701","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA832701_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA832701.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA832701.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA832701.csv.gz"}},{"accession":"PRJNA510036","age_categories":{"adult":17},"countries":{"RU":17},"first_public_year":"2018","gbp_per_sample_median":5.14,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":17},"intervention_design":"single_arm_before_after","intervention_detail":"Capsule fecal microbiota transplantation in healthy volunteers, before/after","interventions":["fmt"],"n_samples":17,"papers":[{"doi":"10.1186/s12866-019-1689-y","pmcid":"PMC6938016","pmid":"31888470","title":"Long-term impact of fecal transplantation in healthy volunteers."},{"doi":"10.1128/msystems.00811-21","pmcid":"PMC8407411","pmid":"34402648","title":"Separation of Donor and Recipient Microbial Diversity Allows Determination of Taxonomic and Functional Features of Gut Microbiota Restructuring following Fecal Transplantation."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal transplant influence on healthy volunteers","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA510036","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA510036_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA510036.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA510036.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA510036.csv.gz"}},{"accession":"PRJNA855302","age_categories":{"adult":16},"countries":{},"first_public_year":"2022","gbp_per_sample_median":11.66,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":2,"ibs":14},"intervention_design":"non_randomized_controlled","intervention_detail":"Different treatment methods for IBS, effect on flora","interventions":["other_intervention"],"n_samples":16,"papers":[],"sample_intervention_arms":{"fmt":2,"no_intervention":2,"other_intervention":2,"probiotic":4},"sex":{"male":16},"title":"Homo sapiens Raw sequence reads","trial_population_condition":"ibs","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA855302","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA855302_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA855302.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA855302.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA855302.csv.gz"}},{"accession":"PRJDB39536","age_categories":{"unknown":15},"countries":{},"first_public_year":"2026","gbp_per_sample_median":68.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"none","intervention_detail":"","interventions":[],"n_samples":15,"papers":[{"doi":"10.1101/2024.09.10.612220","pmcid":null,"pmid":null,"title":"Large-scale single-cell long-read genomics enables high-resolution microbiome profiling"}],"sample_intervention_arms":{"antibiotic":6,"fmt":4,"no_intervention":5},"sex":{},"title":"Large-scale single-cell long-read genomics enables high-resolution microbiome profiling (PRJCA047574)","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJDB39536","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB39536_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJDB39536.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJDB39536.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJDB39536.csv.gz"}},{"accession":"PRJNA339012","age_categories":{"adult":15},"countries":{"US":15},"first_public_year":"2017","gbp_per_sample_median":4.43,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplant from donors to recipients for recurrent C. difficile infection","interventions":["fmt"],"n_samples":15,"papers":[{"doi":"10.1038/s41522-017-0020-7","pmcid":"PMC5462795","pmid":"28649413","title":"Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile."},{"doi":"10.1038/s41467-024-47272-x","pmcid":"PMC11009399","pmid":"38605009","title":"Plasmids in the human gut reveal neutral dispersal and recombination that is overpowered by inflammatory diseases."},{"doi":"10.21203/rs.3.rs-3272455/v1","pmcid":null,"pmid":null,"title":"Plasmid dispersal and recombination across human gut microbiomes is neutral, but overpowered by inflammatory diseases"}],"sample_intervention_arms":{"fmt":9,"no_intervention":6},"sex":{},"title":"Metagenomics analysis of donor and recepient samples from fecal transplant for Recurrent Clostridium difficile infection","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA339012","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA339012_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA339012.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA339012.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA339012.csv.gz"}},{"accession":"PRJNA413199","age_categories":{"unknown":15},"countries":{"US":15},"first_public_year":"2019","gbp_per_sample_median":0.3,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":15},"intervention_design":"observational_with_procedure","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile infection","interventions":["fmt"],"n_samples":15,"papers":[{"doi":"10.7554/elife.40553","pmcid":"PMC6342524","pmid":"30666957","title":"Gut microbiota density influences host physiology and is shaped by host and microbial factors."}],"sample_intervention_arms":{"no_intervention":15},"sex":{},"title":"The absolute gut microbiome alters host physiology, varies by gut architecture and disease, and predicts response to therapy","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA413199","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA413199_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA413199.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA413199.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA413199.csv.gz"}},{"accession":"PRJNA995907","age_categories":{"unknown":15},"countries":{"CN":15},"first_public_year":"2024","gbp_per_sample_median":15.32,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT for COVID-19 treatment","interventions":["fmt"],"n_samples":15,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"Fecal microbiota transplantation for the Treatment of COVID-19","trial_population_condition":"other_infection","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA995907","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA995907_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA995907.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA995907.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA995907.csv.gz"}},{"accession":"PRJEB80456","age_categories":{"unknown":12},"countries":{"US":12},"first_public_year":"2024","gbp_per_sample_median":35.15,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"Autologous FMT after amoxicillin treatment in infant","interventions":["antibiotic","fmt"],"n_samples":12,"papers":[{"doi":"10.1128/mbio.00711-26","pmcid":"PMC13343926","pmid":"42214386","title":"Autologous fecal microbiota transplantation restores the infant gut microbiome and metabolome after antibiotics: a case report."}],"sample_intervention_arms":{},"sex":{},"title":"afmt sample deep sequencing metagenomic and HiC","trial_population_condition":"preterm_nicu","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB80456","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB80456_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB80456.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB80456.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB80456.csv.gz"}},{"accession":"PRJNA438164","age_categories":{"child":12},"countries":{"US":12},"first_public_year":"2018","gbp_per_sample_median":0.35,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":4,"ulcerative_colitis":8},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation in pediatric ulcerative colitis","interventions":["fmt"],"n_samples":12,"papers":[{"doi":"10.1093/femsec/fiy133","pmcid":"PMC6454419","pmid":"30010747","title":"Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients."},{"doi":"10.1128/spectrum.02159-21","pmcid":"PMC9927247","pmid":"36472435","title":"A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process."},{"doi":"10.1016/j.isci.2024.111442","pmcid":"PMC11650326","pmid":"39691780","title":"Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease."},{"doi":"10.1186/s40168-025-02046-5","pmcid":"PMC12180181","pmid":"40542451","title":"Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation."}],"sample_intervention_arms":{"fmt":4,"no_intervention":4,"placebo":4},"sex":{},"title":"Gut microbial profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA438164","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA438164_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA438164.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA438164.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA438164.csv.gz"}},{"accession":"PRJNA803517","age_categories":{"adult":12},"countries":{"US":12},"first_public_year":"2023","gbp_per_sample_median":4.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from healthy donors as salvage therapy for refractory ICI-induced colitis","interventions":["fmt"],"n_samples":12,"papers":[{"doi":"10.1126/scitranslmed.abq4006","pmcid":"PMC10759507","pmid":"37315113","title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis."}],"sample_intervention_arms":{"fmt":6,"no_intervention":6},"sex":{},"title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA803517","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA803517_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA803517.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA803517.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA803517.csv.gz"}},{"accession":"PRJNA812583","age_categories":{"infant":3,"unknown":9},"countries":{"DK":12},"first_public_year":"2022","gbp_per_sample_median":8.28,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":2},"intervention_design":"single_arm_before_after","intervention_detail":"FMT via colonoscopy for CDI during pregnancy","interventions":["fmt"],"n_samples":12,"papers":[{"doi":"10.1186/s40168-022-01394-w","pmcid":"PMC9647999","pmid":"36352460","title":"Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report."}],"sample_intervention_arms":{"fmt":7},"sex":{},"title":"Strain-level metagenomics reveal microbial transfer from donor to infant after fecal microbiota transplantation of pregnant patient","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA812583","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA812583_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA812583.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA812583.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA812583.csv.gz"}},{"accession":"PRJNA1521393","age_categories":{"adult":11},"countries":{"RU":11},"first_public_year":"2026","gbp_per_sample_median":0.29,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":1,"ulcerative_colitis":9},"intervention_design":"single_arm_before_after","intervention_detail":"Sterile fecal filtrate transfer (filtrate FMT) from healthy donors to UC patients","interventions":["fmt"],"n_samples":11,"papers":[],"sample_intervention_arms":{"no_intervention":3,"other_intervention":6},"sex":{},"title":"First clinical cases of effective sterile fecal filtrate transfer for ulcerative colitis treatment: microbiome and virome shifts","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1521393","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1521393_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1521393.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1521393.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1521393.csv.gz"}},{"accession":"PRJNA1025870","age_categories":{"unknown":10},"countries":{"CN":10},"first_public_year":"2024","gbp_per_sample_median":6.61,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":4,"neurological_psychiatric":6},"intervention_design":"single_arm_before_after","intervention_detail":"FMT for ALS respiratory failure, two patients","interventions":["fmt"],"n_samples":10,"papers":[{"doi":"10.1080/19490976.2024.2353396","pmcid":"PMC11123505","pmid":"38778483","title":"Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis."}],"sample_intervention_arms":{"fmt":6,"no_intervention":4},"sex":{},"title":"Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1025870","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1025870_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1025870.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1025870.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1025870.csv.gz"}},{"accession":"PRJNA353655","age_categories":{"adult":10},"countries":{"US":10},"first_public_year":"2016","gbp_per_sample_median":8.35,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"unknown","intervention_detail":"Fecal microbiota transplantation in CDI patients","interventions":["fmt"],"n_samples":10,"papers":[{"doi":"10.1186/s40168-017-0270-x","pmcid":"PMC5418705","pmid":"28473000","title":"Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics."},{"doi":"10.7717/peerj.4227","pmcid":"PMC5768174","pmid":"29340239","title":"FastViromeExplorer: a pipeline for virus and phage identification and abundance profiling in metagenomics data."},{"doi":"10.1016/j.chom.2021.05.008","pmcid":"PMC8288446","pmid":"34111423","title":"Dispersal strategies shape persistence and evolution of human gut bacteria."},{"doi":"10.1128/msystems.00811-21","pmcid":"PMC8407411","pmid":"34402648","title":"Separation of Donor and Recipient Microbial Diversity Allows Determination of Taxonomic and Functional Features of Gut Microbiota Restructuring following Fecal Transplantation."},{"doi":"10.1080/19490976.2022.2135963","pmcid":"PMC9621045","pmid":"36289064","title":"Functional profile of host microbiome indicates Clostridioides difficile infection."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal Microbiota Transplantation experiments","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA353655","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA353655_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA353655.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA353655.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA353655.csv.gz"}},{"accession":"PRJNA484151","age_categories":{"unknown":10},"countries":{"US":10},"first_public_year":"2018","gbp_per_sample_median":0.79,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{},"intervention_design":"observational_with_procedure","intervention_detail":"Infant fecal microbiota transplant into gnotobiotic/germ-free piglets","interventions":["fmt"],"n_samples":10,"papers":[{"doi":"10.3389/fimmu.2019.01509","pmcid":"PMC6648804","pmid":"31379808","title":"Amish (Rural) vs. non-Amish (Urban) Infant Fecal Microbiotas Are Highly Diverse and Their Transplantation Lead to Differences in Mucosal Immune Maturation in a Humanized Germfree Piglet Model."},{"doi":"10.3389/fmicb.2020.00932","pmcid":"PMC7248251","pmid":"32508773","title":"Impact of Microbiota Transplant on Resistome of Gut Microbiota in Gnotobiotic Piglets and Human Subjects."}],"sample_intervention_arms":{},"sex":{},"title":"Rural and Urban infant's fecal microbiota study","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA484151","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA484151_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA484151.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA484151.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA484151.csv.gz"}},{"accession":"PRJNA904560","age_categories":{"adult":9,"elderly":1},"countries":{"CN":10},"first_public_year":"2023","gbp_per_sample_median":11.05,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":5,"neurological_psychiatric":5},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from ET patients to mice; L. plantarum L5 probiotic treatment in mice","interventions":["fmt","probiotic"],"n_samples":10,"papers":[{"doi":"10.1186/s40035-023-00391-9","pmcid":"PMC10717605","pmid":"38093327","title":"Supplementation with high-GABA-producing Lactobacillus plantarum L5 ameliorates essential tremor triggered by decreased gut bacteria-derived GABA."}],"sample_intervention_arms":{},"sex":{"female":1,"male":4},"title":"Essential tremor triggered by reduction of gut bacterial-derived GABA is ameliorated by supplementary of high GABA-producing Lactobacillus plantarum L5","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA904560","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA904560_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA904560.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA904560.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA904560.csv.gz"}},{"accession":"PRJNA1458179","age_categories":{"child":9},"countries":{"CN":9},"first_public_year":"2026","gbp_per_sample_median":11.24,"has_cases_and_healthy_controls":true,"has_treated_and_control_arms":true,"health_conditions":{"healthy_control":3,"neurological_psychiatric":6},"intervention_design":"single_arm_before_after","intervention_detail":"Washed microbiota transplantation in ASD twin, baseline vs post-intervention","interventions":["fmt"],"n_samples":9,"papers":[{"doi":"10.3389/fmicb.2026.1885281","pmcid":"PMC13431265","pmid":"42549413","title":"Washed microbiota transplantation improves clinical symptoms, gut microbiota, and metabolic profiles in autism spectrum disorder in a twin cohort."}],"sample_intervention_arms":{"fmt":3,"no_intervention":6},"sex":{},"title":"Washing Microbiota Transplantation Improves Clinical Symptoms, Gut Microbiota and Metabolic Profiles in Twins with Autism Spectrum Disorder","trial_population_condition":"neurological_psychiatric","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1458179","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1458179_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1458179.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1458179.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1458179.csv.gz"}},{"accession":"PRJNA732769","age_categories":{"adult":9},"countries":{"CA":9},"first_public_year":"2021","gbp_per_sample_median":0.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":5},"intervention_design":"non_randomized_controlled","intervention_detail":"Fecal VLP (phage) transplant from UC patients or healthy controls into HMA mice, +/- DSS colitis","interventions":["fmt","phage_therapy"],"n_samples":9,"papers":[{"doi":"10.1186/s40168-022-01275-2","pmcid":"PMC9264660","pmid":"35799219","title":"Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis."}],"sample_intervention_arms":{},"sex":{},"title":"The impact of bacteriophages on DSS-colitis and microbiota composition - VLP shotgun","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA732769","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA732769_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA732769.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA732769.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA732769.csv.gz"}},{"accession":"PRJNA1480958","age_categories":{"unknown":7},"countries":{"CN":7},"first_public_year":"2026","gbp_per_sample_median":106.73,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"ulcerative_colitis":7},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation, 3 FMTs in UC patients","interventions":["fmt"],"n_samples":7,"papers":[],"sample_intervention_arms":{},"sex":{},"title":"PacBio Long-reads Sequencing for FMT","trial_population_condition":"ulcerative_colitis","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1480958","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1480958_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1480958.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1480958.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1480958.csv.gz"}},{"accession":"PRJNA446061","age_categories":{"adult":7},"countries":{"US":7},"first_public_year":"2018","gbp_per_sample_median":0.7,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":7},"intervention_design":"randomized_controlled_trial","intervention_detail":"5 days Amox-Clav then randomized autoFMT enema vs saline enema","interventions":["antibiotic","fmt"],"n_samples":7,"papers":[{"doi":"10.1128/mspheredirect.00588-18","pmcid":"PMC6249645","pmid":"30463925","title":"Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential."}],"sample_intervention_arms":{},"sex":{},"title":"Fecal Metagenome","trial_population_condition":"healthy_control","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA446061","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA446061_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA446061.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA446061.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA446061.csv.gz"}},{"accession":"PRJNA529230","age_categories":{"adult":7},"countries":{"US":7},"first_public_year":"2019","gbp_per_sample_median":1.2,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"neurological_psychiatric":7},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation, single-subject time series","interventions":["fmt"],"n_samples":7,"papers":[{"doi":"10.3389/fneur.2020.00978","pmcid":"PMC7506051","pmid":"33013647","title":"Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis."}],"sample_intervention_arms":{"no_intervention":1},"sex":{},"title":"n of 1 study: Fecal Microbiota Transplantation in Multiple Sclerosis","trial_population_condition":"autoimmune_inflammatory","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA529230","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA529230_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA529230.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA529230.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA529230.csv.gz"}},{"accession":"PRJNA1131085","age_categories":{"adult":6},"countries":{"CN":6},"first_public_year":"2025","gbp_per_sample_median":3.92,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":6},"intervention_design":"observational_with_procedure","intervention_detail":"Inulin given to PCOS donors; stool FMT to recipient mice","interventions":["fmt","prebiotic_or_fibre"],"n_samples":6,"papers":[{"doi":"10.1002/advs.202412558","pmcid":"PMC12120758","pmid":"40192074","title":"Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome."}],"sample_intervention_arms":{},"sex":{"female":6},"title":"Gut micriobiota in fecal microbiota transplantation trail","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1131085","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1131085_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1131085.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1131085.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1131085.csv.gz"}},{"accession":"PRJNA981221","age_categories":{"unknown":6},"countries":{"US":6},"first_public_year":"2023","gbp_per_sample_median":11.04,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"crohns_disease":2,"healthy_control":2},"intervention_design":"single_arm_before_after","intervention_detail":"FMT from Crohn's disease patients into germ-free mice","interventions":["fmt"],"n_samples":6,"papers":[{"doi":"10.1080/19490976.2024.2333483","pmcid":"PMC10978031","pmid":"38532703","title":"Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis."}],"sample_intervention_arms":{},"sex":{"female":2,"male":2},"title":"GNOTO","trial_population_condition":"crohns_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA981221","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA981221_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA981221.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA981221.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA981221.csv.gz"}},{"accession":"PRJNA743023","age_categories":{"adult":1,"infant":4},"countries":{"US":5},"first_public_year":"2021","gbp_per_sample_median":10.41,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"healthy_control":1,"intervention_cohort":4},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation; pre-FMT vs post-FMT recipient samples and donor samples","interventions":["fmt"],"n_samples":5,"papers":[{"doi":"10.1101/2023.02.10.528096","pmcid":null,"pmid":null,"title":"SeqScreen-Nano: a computational platform for rapid, in-field characterization of previously unseen pathogens"},{"doi":"10.1016/j.csbj.2022.06.019","pmcid":"PMC9249589","pmid":"35832621","title":"KOMB: K-core based de novo characterization of copy number variation in microbiomes."}],"sample_intervention_arms":{"fmt":2,"no_intervention":3},"sex":{"male":4},"title":"Human FMT samples Raw sequence reads","trial_population_condition":"unknown","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA743023","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA743023_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA743023.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA743023.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA743023.csv.gz"}},{"accession":"PRJNA1188549","age_categories":{"unknown":4},"countries":{"ES":4},"first_public_year":"2024","gbp_per_sample_median":8.09,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"other_disease":4},"intervention_design":"single_arm_before_after","intervention_detail":"Two sequential FMTs for auto-brewery syndrome","interventions":["fmt"],"n_samples":4,"papers":[{"doi":"10.1016/j.jhep.2024.12.005","pmcid":null,"pmid":"39647535","title":"Fecal microbiota transplantation in a long-standing auto-brewery syndrome with complex symptomatology."}],"sample_intervention_arms":{"fmt":2,"no_intervention":2},"sex":{},"title":"Fecal Microbiota Transplantation in a Long-Standing Auto-Brewery Syndrome with Complex Symptomatology","trial_population_condition":"other_disease","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJNA1188549","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1188549_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJNA1188549.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJNA1188549.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJNA1188549.csv.gz"}},{"accession":"PRJEB89891","age_categories":{"unknown":2},"countries":{"CH":2},"first_public_year":"2026","gbp_per_sample_median":5.81,"has_cases_and_healthy_controls":false,"has_treated_and_control_arms":false,"health_conditions":{"gi_infection_or_diarrhoea":2},"intervention_design":"single_arm_before_after","intervention_detail":"Fecal microbiota transplantation for recurrent C. difficile infection","interventions":["fmt"],"n_samples":2,"papers":[{"doi":"10.3390/microorganisms14010217","pmcid":"PMC12844390","pmid":"41597735","title":"Fecal Microbiota Transplantation Donor Screening: Is Dientamoeba fragilis a Valid Criterion for Donor Exclusion? A Longitudinal Study of a Swiss Cohort."}],"sample_intervention_arms":{"fmt":1,"no_intervention":1},"sex":{},"title":"First Human Transmission of Dientamoeba fragilis via Fecal Microbiota Transplantation: A new argument for apathogenicity","trial_population_condition":"gi_infection_or_diarrhoea","urls":{"ena":"https://www.ebi.ac.uk/ena/browser/view/PRJEB89891","evidence_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB89891_determinations.csv.gz","page":"https://olmlab.github.io/microbiome_repo/studies/PRJEB89891.html","samples_csv":"https://olmlab.github.io/microbiome_repo/api/samples/PRJEB89891.csv","samples_full_csv_gz":"https://olmlab.github.io/microbiome_repo/data/studies/PRJEB89891.csv.gz"}}],"release":"R2026.25"}